BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry 2021;8:416-27. [PMID: 33836148 DOI: 10.1016/S2215-0366(21)00084-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 78] [Article Influence: 137.0] [Reference Citation Analysis]
Number Citing Articles
1 Murray E, Kaufman KR, Williams R. Let us do better: learning lessons for recovery of healthcare professionals during and after COVID-19. BJPsych Open 2021;7:e151. [PMID: 34457351 DOI: 10.1192/bjo.2021.981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Taquet M, Holmes EA, Harrison PJ. Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns. Lancet 2021;398:1665-6. [PMID: 34634251 DOI: 10.1016/S0140-6736(21)02221-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rudroff T, Workman CD, Bryant AD. Potential Factors That Contribute to Post-COVID-19 Fatigue in Women. Brain Sciences 2022;12:556. [DOI: 10.3390/brainsci12050556] [Reference Citation Analysis]
4 Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, Lui LMW, Subramaniapillai M, Gill H, Liu RN, Joseph P, Teopiz KM, Cao B, Mansur RB, Lin K, Rosenblat JD, Ho RC, McIntyre RS. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis. JAMA Psychiatry 2021. [PMID: 34319365 DOI: 10.1001/jamapsychiatry.2021.1818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Weich S. Mental health after covid-19. BMJ 2022;376:o326. [PMID: 35172977 DOI: 10.1136/bmj.o326] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 Damiano RF, Neto DB, Oliveira JVR, Magalhães Santos J, Alves JVR, Guedes BF, Nitrini R, de Araújo AL, Oliveira M, Brunoni AR, Voegels RL, Bento RF, Busatto G, Miguel EC, Forlenza OV, de Rezende Pinna F; HCFMUSP COVID-19 study group. Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35633395 DOI: 10.1007/s00406-022-01427-3] [Reference Citation Analysis]
7 Shen W. Dynamically adjusted strategy in response to developments in the COVID-19 pandemic as a new normal. Global Health 2021;17:89. [PMID: 34372862 DOI: 10.1186/s12992-021-00746-9] [Reference Citation Analysis]
8 Butler M, Cross B, Hafeez D, Lim MF, Morrin H, Rengasamy ER, Pollak T, Nicholson TR. Emerging Knowledge of the Neurobiology of COVID-19. Psychiatric Clinics of North America 2021. [DOI: 10.1016/j.psc.2021.11.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 O'Regan D, Jackson ML, Young AH, Rosenzweig I. Understanding the Impact of the COVID-19 Pandemic, Lockdowns and Social Isolation on Sleep Quality. Nat Sci Sleep 2021;13:2053-64. [PMID: 34795545 DOI: 10.2147/NSS.S266240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 Calabria M, García-Sánchez C, Grunden N, Pons C, Arroyo JA, Gómez-Anson B, Estévez García MDC, Belvís R, Morollón N, Vera Igual J, Mur I, Pomar V, Domingo P. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J Neurol 2022. [PMID: 35488918 DOI: 10.1007/s00415-022-11141-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Begemann M, Gross O, Wincewicz D, Hardeland R, Daguano Gastaldi V, Vieta E, Weissenborn K, Miskowiak KW, Moerer O, Ehrenreich H. Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues. Mol Med 2021;27:120. [PMID: 34565332 DOI: 10.1186/s10020-021-00381-5] [Reference Citation Analysis]
12 Seidel H, Hertfelder HJ, Oldenburg J, Kruppenbacher JP, Afrin LB, Molderings GJ. Effects of Primary Mast Cell Disease on Hemostasis and Erythropoiesis. Int J Mol Sci 2021;22:8960. [PMID: 34445665 DOI: 10.3390/ijms22168960] [Reference Citation Analysis]
13 Al-Hashel JY, Abokalawa F, Alenzi M, Alroughani R, Ahmed SF. Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study. J Headache Pain 2021;22:97. [PMID: 34418950 DOI: 10.1186/s10194-021-01314-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Etyemez S, Narita Z, Mihaljevic M, Coughlin JM, Nestadt G, Nucifora FCJ, Sedlak TW, Cascella NG, Batt FD, Hua J, Faria A, Ishizuka K, Kamath V, Yang K, Sawa A. Brain regions associated with olfactory dysfunction in first episode psychosis patients. World J Biol Psychiatry 2022;:1-9. [PMID: 35678361 DOI: 10.1080/15622975.2022.2082526] [Reference Citation Analysis]
15 Gallagher MW, Smith LJ, Richardson AL, Long LJ. Six Month Trajectories of COVID-19 Experiences and Associated Stress, Anxiety, Depression, and Impairment in American Adults. Cognit Ther Res 2021;:1-13. [PMID: 34803195 DOI: 10.1007/s10608-021-10277-7] [Reference Citation Analysis]
16 Ho A. Can Public Health Investment and Oversight save Digital Mental Health? AJOB Neurosci 2022;13:201-3. [PMID: 35797129 DOI: 10.1080/21507740.2022.2082586] [Reference Citation Analysis]
17 Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review. Brain Behav Immun 2021:S0889-1591(21)00281-6. [PMID: 34339806 DOI: 10.1016/j.bbi.2021.07.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Abel KM, Carr MJ, Ashcroft DM, Chalder T, Chew-Graham CA, Hope H, Kapur N, McManus S, Steeg S, Webb RT, Pierce M. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients. JAMA Netw Open 2021;4:e2134803. [PMID: 34783824 DOI: 10.1001/jamanetworkopen.2021.34803] [Reference Citation Analysis]
19 Rogers-Brown JS, Wanga V, Okoro C, Brozowsky D, Evans A, Hopwood D, Cope JR, Jackson BR, Bushman D, Hernandez-Romieu AC, Bonacci RA, McLeod T, Chevinsky JR, Goodman AB, Dixon MG, Lutfy C, Rushmore J, Koumans E, Morris SB, Thompson W. Outcomes Among Patients Referred to Outpatient Rehabilitation Clinics After COVID-19 diagnosis - United States, January 2020-March 2021. MMWR Morb Mortal Wkly Rep 2021;70:967-71. [PMID: 34237048 DOI: 10.15585/mmwr.mm7027a2] [Reference Citation Analysis]
20 Harper S. The Impact of the Covid-19 Pandemic on Global Population Ageing. J Popul Ageing 2021;:1-6. [PMID: 34055101 DOI: 10.1007/s12062-021-09330-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Dias Araújo Freitas FE, Carlos Batista MA, Cristina de Assis Braga D, Brandino de Oliveira L, Antunes VR, Cardoso LM. The gut-brain axis and sodium appetite: Can inflammation-related signaling influence the control of sodium intake? Appetite 2022;:106050. [PMID: 35447164 DOI: 10.1016/j.appet.2022.106050] [Reference Citation Analysis]
22 Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord 2021;299:118-25. [PMID: 34798148 DOI: 10.1016/j.jad.2021.11.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 23.0] [Reference Citation Analysis]
23 Hugon J, Queneau M, Sanchez Ortiz M, Msika EF, Farid K, Paquet C. Cognitive decline and brainstem hypometabolism in long COVID: A case series. Brain Behav 2022;:e32513. [PMID: 35290729 DOI: 10.1002/brb3.2513] [Reference Citation Analysis]
24 Fujii R, Konno Y, Tateishi S, Hino A, Tsuji M, Ikegami K, Nagata M, Yoshimura R, Matsuda S, Fujino Y. Association Between Time Spent With Family and Loneliness Among Japanese Workers During the COVID-19 Pandemic: A Cross-Sectional Study. Front Psychiatry 2021;12:786400. [PMID: 34955931 DOI: 10.3389/fpsyt.2021.786400] [Reference Citation Analysis]
25 Wildi K, Li Bassi G, Barnett A, Panigada M, Colombo SM, Bandera A, Muscatello A, McNicholas B, Laffey JG, Battaglini D, Robba C, Torres A, Motos A, Luna CM, Rainieri F, Hodgson C, Burrell AJC, Buscher H, Dalton H, Cho SM, Choi HA, Thomson D, Suen J, Fraser JF. Design and Rationale of a Prospective International Follow-Up Study on Intensive Care Survivors of COVID-19: The Long-Term Impact in Intensive Care Survivors of Coronavirus Disease-19-AFTERCOR. Front Med (Lausanne) 2021;8:738086. [PMID: 34568393 DOI: 10.3389/fmed.2021.738086] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Jacobsen PA, Andersen MP, Gislason G, Phelps M, Butt JH, Køber L, Schou M, Fosbøl E, Christensen HC, Torp-Pedersen C, Gerds T, Weinreich UM, Kragholm K. Return to work after COVID-19 infection - A Danish nationwide registry study. Public Health 2022;203:116-22. [PMID: 35038630 DOI: 10.1016/j.puhe.2021.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tripathy S, Singh N, Singh A, Kar SK. COVID-19 and Psychotic Symptoms: the View from Psychiatric Immunology. Curr Behav Neurosci Rep 2021;:1-7. [PMID: 34631364 DOI: 10.1007/s40473-021-00235-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Brimson JM, Prasanth MI, Malar DS, Brimson S, Thitilertdecha P, Tencomnao T. Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy. Expert Opin Ther Targets 2021;:1-15. [PMID: 34236922 DOI: 10.1080/14728222.2021.1952987] [Reference Citation Analysis]
29 Zhao S, Shibata K, Hellyer PJ, Trender W, Manohar S, Hampshire A, Husain M. Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Communications 2022;4:fcab295. [DOI: 10.1093/braincomms/fcab295] [Reference Citation Analysis]
30 Patnaik S, Jain MK, Ahmed S, Dash AK, P RK, Sahoo B, Mishra R, Behera MR. Short-term outcomes in children recovered from multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Rheumatol Int 2021. [PMID: 34259880 DOI: 10.1007/s00296-021-04932-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Damiano RF, Caruso MJG, Cincoto AV, de Almeida Rocca CC, de Pádua Serafim A, Bacchi P, Guedes BF, Brunoni AR, Pan PM, Nitrini R, Beach S, Fricchione G, Busatto G, Miguel EC, Forlenza OV. Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study. General Hospital Psychiatry 2022. [DOI: 10.1016/j.genhosppsych.2022.01.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
32 Ismail II, Al-hashel J, Alroughani R, Ahmed SF. A case report of multiple sclerosis after COVID-19 infection: causality or coincidence? Neuroimmunology Reports 2021;1:100008. [DOI: 10.1016/j.nerep.2021.100008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Graff LA, Fowler S, Jones JL, Benchimol EI, Bitton A, Huang JG, Kuenzig ME, Kaplan GG, Lee K, Mukhtar MS, Tandon P, Targownik LE, Windsor JW, Bernstein CN. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life. J Can Assoc Gastroenterol 2021;4:S46-53. [PMID: 34755039 DOI: 10.1093/jcag/gwab031] [Reference Citation Analysis]
34 Latoo J, Haddad PM, Mistry M, Wadoo O, Islam SMS, Jan F, Iqbal Y, Howseman T, Riley D, Alabdulla M. The COVID-19 pandemic: an opportunity to make mental health a higher public health priority. BJPsych Open 2021;7:e172. [PMID: 34538286 DOI: 10.1192/bjo.2021.1002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Vuorio A, Raal F, Ijäs P, Kaste M, Kovanen PT. Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial Hypercholesterolemia. Front Pharmacol 2022;13:890141. [PMID: 35645833 DOI: 10.3389/fphar.2022.890141] [Reference Citation Analysis]
36 Lee JH, Lee D, Hyun S, Hong JS, Kim CH, Kim W, Sim M. Online Mental Health Assessments of COVID-19 Patients in South Korea. Front Psychiatry 2021;12:685445. [PMID: 34295275 DOI: 10.3389/fpsyt.2021.685445] [Reference Citation Analysis]
37 Villalpando JMG, Forcelledo HA, Castillo JLB, Sastré AJ, Rojop IEJ, Hernández VO, Canabal FEM, Priego CGG. COVID-19, Long COVID Syndrome, and Mental Health Sequelae in a Mexican Population. Int J Environ Res Public Health 2022;19:6970. [PMID: 35742219 DOI: 10.3390/ijerph19126970] [Reference Citation Analysis]
38 Nirisha PL, Bhaskaran AS, Yedavally NA, Suchandra HH, Manjunatha N, Kumar CN, Math SB. First episode psychosis and COVID-19: A Case series and Mini review. Asian Journal of Psychiatry 2022. [DOI: 10.1016/j.ajp.2022.103123] [Reference Citation Analysis]
39 Degen CV, Mikuteit M, Niewolik J, Schröder D, Vahldiek K, Mücke U, Heinemann S, Müller F, Behrens GMN, Klawonn F, Dopfer-Jablonka A, Steffens S. Self-reported Tinnitus and Vertigo or Dizziness in a Cohort of Adult Long COVID Patients. Front Neurol 2022;13:884002. [PMID: 35547372 DOI: 10.3389/fneur.2022.884002] [Reference Citation Analysis]
40 Dampalla CS, Zheng J, Perera KD, Wong LR, Meyerholz DK, Nguyen HN, Kashipathy MM, Battaile KP, Lovell S, Kim Y, Perlman S, Groutas WC, Chang KO. Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection. Proc Natl Acad Sci U S A 2021;118:e2101555118. [PMID: 34210738 DOI: 10.1073/pnas.2101555118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Haage V, De Jager PL. Neuroimmune contributions to Alzheimer's disease: a focus on human data. Mol Psychiatry 2022. [PMID: 35668160 DOI: 10.1038/s41380-022-01637-0] [Reference Citation Analysis]
42 Long B, Carius BM, Liang SY, Chavez S, Brady WJ, Koyfman A, Gottlieb M. Clinical update on COVID-19 for the emergency clinician: Presentation and evaluation. The American Journal of Emergency Medicine 2022. [DOI: 10.1016/j.ajem.2022.01.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 14.0] [Reference Citation Analysis]
43 Zhang Y, Chen X, Jia L, Zhang Y. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment. Acta Neurol Scand 2022. [PMID: 35699161 DOI: 10.1111/ane.13657] [Reference Citation Analysis]
44 Hrzic R, Peixoto VR, Mason-Jones AJ, McCallum A; ASPHER COVID-19 Task Force. Is it really time to ditch the mask? BMJ 2022;377:o1186. [PMID: 35545285 DOI: 10.1136/bmj.o1186] [Reference Citation Analysis]
45 Sørensen AIV, Spiliopoulos L, Bager P, Nielsen NM, Hansen JV, Koch A, Meder IK, Ethelberg S, Hviid A. A nationwide questionnaire study of post-acute symptoms and health problems after SARS-CoV-2 infection in Denmark. Nat Commun 2022;13:4213. [PMID: 35864108 DOI: 10.1038/s41467-022-31897-x] [Reference Citation Analysis]
46 Gramaglia C, Gattoni E, Gambaro E, Bellan M, Balbo PE, Baricich A, Sainaghi PP, Pirisi M, Binda V, Feggi A, Jona A, Marangon D, Prosperini P, Zeppegno P. Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up. Front Psychiatry 2022;13:862651. [DOI: 10.3389/fpsyt.2022.862651] [Reference Citation Analysis]
47 Du Y, Zhao W, Du L, Liu J. Neuropsychiatric symptoms associated with the COVID-19 and its potential nervous system infection mechanism: the role of imaging in the study. Psychoradiology 2021;1:199-211. [DOI: 10.1093/psyrad/kkab019] [Reference Citation Analysis]
48 Wu D, Ding H, Lin J, Xiao M, Xie J, Xie F, Zhang S. Fighting COVID-19: a qualitative study into the lives of intensive care unit survivors in Wuhan, China. BMJ Open 2022;12:e055365. [DOI: 10.1136/bmjopen-2021-055365] [Reference Citation Analysis]
49 O'Donoghue B, Collett H, Boyd S, Zhou Y, Castagnini E, Brown E, Street R, Nelson B, Thompson A, McGorry P. The incidence and admission rate for first-episode psychosis in young people before and during the COVID-19 pandemic in Melbourne, Australia. Aust N Z J Psychiatry 2021;:48674211053578. [PMID: 34651504 DOI: 10.1177/00048674211053578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Botha F, Butterworth P, Wilkins R. Evaluating How Mental Health Changed in Australia through the COVID-19 Pandemic: Findings from the 'Taking the Pulse of the Nation' (TTPN) Survey. Int J Environ Res Public Health 2022;19:558. [PMID: 35010819 DOI: 10.3390/ijerph19010558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Valenza M, Steardo L Jr, Steardo L, Verkhratsky A, Scuderi C. Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders. Front Cell Neurosci 2021;15:748136. [PMID: 34912192 DOI: 10.3389/fncel.2021.748136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bellucci G, Rinaldi V, Buscarinu MC, Reniè R, Bigi R, Pellicciari G, Morena E, Romano C, Marrone A, Mechelli R, Salvetti M, Ristori G. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started? Front Immunol 2021;12:755333. [PMID: 34646278 DOI: 10.3389/fimmu.2021.755333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Ormiston CK, Świątkiewicz I, Taub PR. Postural Orthostatic Tachycardia Syndrome as a Sequela of COVID-19. Heart Rhythm 2022:S1547-5271(22)02185-3. [PMID: 35853576 DOI: 10.1016/j.hrthm.2022.07.014] [Reference Citation Analysis]
54 Magnúsdóttir I, Lovik A, Unnarsdóttir AB, Mccartney D, Ask H, Kõiv K, Christoffersen LAN, Johnson SU, Hauksdóttir A, Fawns-ritchie C, Helenius D, González-hijón J, Lu L, Ebrahimi OV, Hoffart A, Porteous DJ, Fang F, Jakobsdóttir J, Lehto K, Andreassen OA, Pedersen OBV, Aspelund T, Valdimarsdóttir UA, Magnúsdóttir I, Lovik A, Unnarsdóttir AB, Mccartney D, Ask H, Kõiv K, Nordahl Christoffersen LA, Johnson SU, Mcintosh A, Kähler AK, Campbell A, Hauksdóttir A, Fawns-ritchie C, Erikstrup C, Helenius D, Altschul D, Thordardottir EB, Eyþórsson E, Frans EM, Tómasson G, Jónsdóttir HL, Rúnarsdóttir H, Hjalgrim H, Harõardóttir H, González-hijón J, Banasik K, Dinh KM, Lu L, Milani L, Trogstad L, Didriksen M, Ebrahimi OV, Sullivan PF, Magnus PM, Shen Q, Nesvåg R, Mägi R, Pálsson R, Ostrowski SR, Werge T, Hoffart A, Porteous DJ, Fang F, Jakobsdóttir J, Lehto K, Andreassen OA, Pedersen OB, Aspelund T, Valdimarsdóttir UA. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. The Lancet Public Health 2022. [DOI: 10.1016/s2468-2667(22)00042-1] [Reference Citation Analysis]
55 Fullana MA, Littarelli SA. Covid-19, anxiety, and anxiety-related disorders. Eur Neuropsychopharmacol 2021;51:87-9. [PMID: 34098517 DOI: 10.1016/j.euroneuro.2021.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Aljumaiah R, Alturaiki W, Alosaimi B. Confusion and Hallucination: A Case Report of an Unusual Presentation of COVID-19. Case Rep Psychiatry 2021;2021:3794019. [PMID: 34984107 DOI: 10.1155/2021/3794019] [Reference Citation Analysis]
57 Majolo F, Silva GLD, Vieira L, Anli C, Timmers LFSM, Laufer S, Goettert MI. Neuropsychiatric Disorders and COVID-19: What We Know So Far. Pharmaceuticals (Basel) 2021;14:933. [PMID: 34577633 DOI: 10.3390/ph14090933] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Tony AA, Ahmed SBA, Tony EAE, Maklad S, Elnakeeb I, Amin MM. Predictors of Neurological Presentations of COVID-19 Infected Patients in South Egypt, Aswan Governorate: A Single Center Study. Neuropsychiatr Dis Treat 2021;17:3471-82. [PMID: 34880616 DOI: 10.2147/NDT.S333109] [Reference Citation Analysis]
59 Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022;101:93-135. [PMID: 34973396 DOI: 10.1016/j.bbi.2021.12.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 53.0] [Reference Citation Analysis]
60 Loft MI, Foged EM, Koreska M. An Unexpected Journey: The Lived Experiences of Patients with Long-Term Cognitive Sequelae After Recovering from COVID-19. Qual Health Res. [DOI: 10.1177/10497323221099467] [Reference Citation Analysis]
61 Kompaniyets L, Pennington AF, Goodman AB, Rosenblum HG, Belay B, Ko JY, Chevinsky JR, Schieber LZ, Summers AD, Lavery AM, Preston LE, Danielson ML, Cui Z, Namulanda G, Yusuf H, Mac Kenzie WR, Wong KK, Baggs J, Boehmer TK, Gundlapalli AV. Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020-March 2021. Prev Chronic Dis 2021;18:E66. [PMID: 34197283 DOI: 10.5888/pcd18.210123] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Garout MA, Saleh SAK, Adly HM, Abdulkhaliq AA, Khafagy AA, Abdeltawab MR, Rabaan AA, Rodriguez-Morales AJ, Al-Tawfiq JA, Alandiyjany MN. Post-COVID-19 syndrome: assessment of short- and long-term post-recovery symptoms in recovered cases in Saudi Arabia. Infection 2022. [PMID: 35294728 DOI: 10.1007/s15010-022-01788-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Chen X, Gao W, Li J, You D, Yu Z, Zhang M, Shao F, Wei Y, Zhang R, Lange T, Wang Q, Chen F, Lu X, Zhao Y. A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers. Brief Bioinform 2021:bbab206. [PMID: 34081102 DOI: 10.1093/bib/bbab206] [Reference Citation Analysis]
64 Wang L, Wang Q, Davis PB, Volkow ND, Xu R. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry 2021. [PMID: 34612005 DOI: 10.1002/wps.20921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 22.0] [Reference Citation Analysis]
65 Brown KM, Robinson GE, Nadelson CC, Grigoriadis S, Mittal LP, Conteh N, Benders-Hadi N, Wald M, Feldman N; GAP Committee on Gender and Mental Health. Psychological Impact of COVID-19 on Minority Women. J Nerv Ment Dis 2021;209:695-6. [PMID: 34582398 DOI: 10.1097/NMD.0000000000001403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Chandra A, Johri A. A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 2022;12:190. [DOI: 10.3390/brainsci12020190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Narita Z, Yamanouchi Y, Mishima K, Kamio Y, Ayabe N, Kakei R, Kim Y. Training types associated with knowledge and experience in public health workers. Arch Public Health 2022;80:44. [PMID: 35086558 DOI: 10.1186/s13690-022-00788-4] [Reference Citation Analysis]
68 Rhally A, Griffa A, Kremer S, Uginet M, Breville G, Stancu P, Assal F, Lalive PH, Lövblad KO, Allali G. C-reactive protein and white matter microstructural changes in COVID-19 patients with encephalopathy. J Neural Transm (Vienna) 2021;128:1899-906. [PMID: 34709472 DOI: 10.1007/s00702-021-02429-6] [Reference Citation Analysis]
69 Del Corral T, Menor-Rodríguez N, Fernández-Vega S, Díaz-Ramos C, Aguilar-Zafra S, López-de-Uralde-Villanueva I. Longitudinal study of changes observed in quality of life, psychological state cognition and pulmonary and functional capacity after COVID-19 infection: A six- to seven-month prospective cohort. J Clin Nurs 2022. [PMID: 35534994 DOI: 10.1111/jocn.16352] [Reference Citation Analysis]
70 Hugon J. LONG-COVID: COGNITIVE DEFICITS (BRAIN FOG) AND BRAIN LESIONS IN NON-HOSPITALIZED PATIENTS. Presse Med 2021;:104090. [PMID: 34718113 DOI: 10.1016/j.lpm.2021.104090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
71 Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine 2021;39:101061. [PMID: 34368663 DOI: 10.1016/j.eclinm.2021.101061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
72 Dacosta-Aguayo R, Lamonja-Vicente N, Chacón C, Carrasco-Ribelles LA, Montero-Alia P, Costa-Garrido A, García-Sierra R, López-Lifante VM, Moreno-Gabriel E, Massanella M, Puig J, Muñoz-Moreno JA, Mateu L, Prats A, Rodríguez C, Mataró M, Prado JG, Martínez-Cáceres E, Violán C, Torán-Monserrat P. Neurocognitive Profile of the Post-COVID Condition in Adults in Catalonia-A Mixed Method Prospective Cohort and Nested Case-Control Study: Study Protocol. Vaccines (Basel) 2022;10:849. [PMID: 35746457 DOI: 10.3390/vaccines10060849] [Reference Citation Analysis]
73 Badalyan KR, Solovyeva EI. COVID-19: long-term health impacts. Consilium Medicum 2021;23:993-9. [DOI: 10.26442/20751753.2021.12.201347] [Reference Citation Analysis]
74 Miskowiak K, Fugledalen L, Jespersen A, Sattler S, Podlekareva D, Rungby J, Porsberg C, Johnsen S. Trajectory of cognitive impairments over 1 year after COVID-19 hospitalisation: pattern, severity, and functional implications. European Neuropsychopharmacology 2022. [DOI: 10.1016/j.euroneuro.2022.04.004] [Reference Citation Analysis]
75 Boesl F, Audebert H, Endres M, Prüss H, Franke C. A Neurological Outpatient Clinic for Patients With Post-COVID-19 Syndrome - A Report on the Clinical Presentations of the First 100 Patients. Front Neurol 2021;12:738405. [PMID: 34603189 DOI: 10.3389/fneur.2021.738405] [Reference Citation Analysis]
76 Valderas C, Méndez G, Echeverría A, Suarez N, Julio K, Sandoval F. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner. World J Pediatr 2022. [PMID: 35476245 DOI: 10.1007/s12519-022-00550-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Mesmoudi S, Lapina C, Rodic M, Peschanski D. Multi-Data Integration Towards a Global Understanding of the Neurological Impact of Human Brain Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Front Integr Neurosci 2022;16:756604. [DOI: 10.3389/fnint.2022.756604] [Reference Citation Analysis]
78 Cecon E, Fernandois D, Renault N, Coelho CFF, Wenzel J, Bedart C, Izabelle C, Gallet S, Le Poder S, Klonjkowski B, Schwaninger M, Prevot V, Dam J, Jockers R. Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels. Cell Mol Life Sci 2022;79:361. [PMID: 35697820 DOI: 10.1007/s00018-022-04390-3] [Reference Citation Analysis]
79 Andrews MG, Mukhtar T, Eze UC, Simoneau CR, Ross J, Parikshak N, Wang S, Zhou L, Koontz M, Velmeshev D, Siebert C, Gemenes KM, Tabata T, Perez Y, Wang L, Mostajo-radji MA, de Majo M, Donohue KC, Shin D, Salma J, Pollen AA, Nowakowski TJ, Ullian E, Kumar GR, Winkler EA, Crouch EE, Ott M, Kriegstein AR. Tropism of SARS-CoV-2 for human cortical astrocytes. Proc Natl Acad Sci U S A 2022;119:e2122236119. [DOI: 10.1073/pnas.2122236119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Harpaz R. COVID-19 vaccine safety monitoring: Might differential healthcare seeking introduce detection bias into rates of medical events and cause false safety signals? Vaccine 2021;39:7366. [PMID: 34474935 DOI: 10.1016/j.vaccine.2021.06.002] [Reference Citation Analysis]
81 Koc HC, Xiao J, Liu W, Li Y, Chen G. Long COVID and its Management. Int J Biol Sci 2022;18:4768-80. [PMID: 35874958 DOI: 10.7150/ijbs.75056] [Reference Citation Analysis]
82 Saeed SA, Pastis IS, Santos MG. COVID-19 and its impact on the brain and Mind- A conceptual model and supporting evidence. Psychiatr Q 2022. [PMID: 35303244 DOI: 10.1007/s11126-022-09980-9] [Reference Citation Analysis]
83 Rhoades R, Solomon S, Johnson C, Teng S. Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders. Front Microbiol 2022;13:845559. [PMID: 35444632 DOI: 10.3389/fmicb.2022.845559] [Reference Citation Analysis]
84 Liu Z, Zhou J, Xu W, Deng W, Wang Y, Wang M, Wang Q, Hsieh M, Dong J, Wang X, Huang W, Xing L, He M, Tao C, Xie Y, Zhang Y, Wang Y, Zhao J, Yuan Z, Qin C, Jiang S, Lu L. A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs. Cell Res. [DOI: 10.1038/s41422-022-00612-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
85 Semerdzhiev SA, Fakhree MAA, Segers-Nolten I, Blum C, Claessens MMAE. Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation. ACS Chem Neurosci 2022;13:143-50. [PMID: 34860005 DOI: 10.1021/acschemneuro.1c00666] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
86 Smith CM, Gilbert EB, Riordan PA, Helmke N, von Isenburg M, Kincaid BR, Shirey KG. COVID-19-associated psychosis: A systematic review of case reports. Gen Hosp Psychiatry 2021;73:84-100. [PMID: 34717240 DOI: 10.1016/j.genhosppsych.2021.10.003] [Reference Citation Analysis]
87 Mitra J, Kodavati M, Provasek VE, Rao KS, Mitra S, Hamilton DJ, Horner PJ, Vahidy FS, Britz GW, Kent TA, Hegde ML. SARS-CoV-2 and the central nervous system: Emerging insights into hemorrhage-associated neurological consequences and therapeutic considerations. Ageing Res Rev 2022;80:101687. [PMID: 35843590 DOI: 10.1016/j.arr.2022.101687] [Reference Citation Analysis]
88 Varela AA, Cheng S, Werren JH. Novel ACE2 protein interactions relevant to COVID-19 predicted by evolutionary rate correlations. PeerJ 2021;9:e12159. [PMID: 34616619 DOI: 10.7717/peerj.12159] [Reference Citation Analysis]
89 Frontera JA, Lewis A, Melmed K, Lin J, Kondziella D, Helbok R, Yaghi S, Meropol S, Wisniewski T, Balcer L, Galetta SL. Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States. Front Aging Neurosci 2021;13:690383. [PMID: 34349633 DOI: 10.3389/fnagi.2021.690383] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Marić N. Mental health and COVID-19 pandemic: The literature review. Medicinski podmladak 2021;72:78-86. [DOI: 10.5937/mp72-32877] [Reference Citation Analysis]
91 Mueller JK, Riederer P, Müller WE. Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence? Pharmacopsychiatry 2022;55:7-15. [DOI: 10.1055/a-1717-2381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Wong-chew RM, Rodríguez Cabrera EX, Rodríguez Valdez CA, Lomelin-gascon J, Morales-juárez L, de la Cerda MLR, Villa-romero AR, Arce Fernández S, Serratos Fernandez M, Bello HH, Castañeda LM, Avendaño MA, Hernández-cruz JA, Álvarez Martínez N, Fernanda Contreras L, Rafael González de la Cerda L, Juárez Flores A, Martínez-juarez LA, Álvarez-hernández D, Gallardo-rincón H, Fajardo Dolci G, Tapia-conyer R, Valdez-vázquez RR. Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City. Therapeutic Advances in Infection 2022;9:204993612110692. [DOI: 10.1177/20499361211069264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Su X, Yue P, Kong J, Xu X, Zhang Y, Cao W, Fan Y, Liu M, Chen J, Liu A, Bao F. Human Brain Organoids as an In Vitro Model System of Viral Infectious Diseases. Front Immunol 2021;12:792316. [PMID: 35087520 DOI: 10.3389/fimmu.2021.792316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
94 Dawood AS, Dawood A, Dawood S. Catatonia after COVID-19 infection: scoping review. BJPsych Bull 2022;:1-12. [PMID: 35670192 DOI: 10.1192/bjb.2022.30] [Reference Citation Analysis]
95 Mølhave M, J A, C W. Clinical Management of COVID-19 Patients - An Update. Semin Nucl Med 2021:S0001-2998(21)00036-2. [PMID: 34243904 DOI: 10.1053/j.semnuclmed.2021.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
96 Zambon A, Rico LC, Herman M, Gundacker A, Telalovic A, Hartenberger LM, Kuehn R, Romanov RA, Hussaini SA, Harkany T, Pollak DD. Gestational immune activation disrupts hypothalamic neurocircuits of maternal care behavior. Mol Psychiatry 2022. [PMID: 35581295 DOI: 10.1038/s41380-022-01602-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J. COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review. Front Psychiatry 2021;12:798554. [PMID: 35095612 DOI: 10.3389/fpsyt.2021.798554] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
98 Ahmed JO, Ahmed SA, Hassan MN, Kakamad FH, Salih RQ, Abdulla BA, Rahim Fattah FH, Mohammed SH, Ali RK, Salih AM. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond) 2022;:103440. [PMID: 35261766 DOI: 10.1016/j.amsu.2022.103440] [Reference Citation Analysis]
99 Iqbal Y, Alabdulla M, Latoo J, Kumar R, Albrahim S, Wadoo O, M Haddad P. Mania and hypomania associated with COVID-19: a series of 15 cases seen by the consultation-liaison psychiatry service in Qatar. Qatar Med J 2021;2021:65. [PMID: 34888201 DOI: 10.5339/qmj.2021.65] [Reference Citation Analysis]
100 Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, Hafeez D, Burchill E, Saini A, Thomas L, Cross B, Hunt CK, Conti I, Ralovska S, Hussain Z, Butler M, Pollak TA, Koychev I, Michael BD, Holling H, Nicholson TR, Rogers JP, Rooney AG. Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Communications 2022;4:fcab297. [DOI: 10.1093/braincomms/fcab297] [Reference Citation Analysis]
101 Jacob L, Koyanagi A, Smith L, Bohlken J, Haro JM, Kostev K. No significant association between COVID-19 diagnosis and the incidence of depression and anxiety disorder? A retrospective cohort study conducted in Germany. J Psychiatr Res 2022;147:79-84. [PMID: 35026596 DOI: 10.1016/j.jpsychires.2022.01.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
102 Ting M, Suzuki JB. SARS-CoV-2: Overview and Its Impact on Oral Health. Biomedicines 2021;9:1690. [PMID: 34829919 DOI: 10.3390/biomedicines9111690] [Reference Citation Analysis]
103 Vadakkan KI. Neurological disorders of COVID-19 can be explained in terms of both "loss and gain of function" states of a solution for the nervous system. Brain Circ 2021;7:217-22. [PMID: 34667907 DOI: 10.4103/bc.bc_46_21] [Reference Citation Analysis]
104 Spinelli A, Willeman T, Roustit M, Stanke-Labesque F. COVID-19 lockdowns and incidence of psychoactive substance exposure according to age and sex. Clin Toxicol (Phila) 2021;:1-6. [PMID: 34904494 DOI: 10.1080/15563650.2021.2013494] [Reference Citation Analysis]
105 Rass V, Ianosi BA, Zamarian L, Beer R, Sahanic S, Lindner A, Kofler M, Schiefecker AJ, Mahlknecht P, Heim B, Limmert V, Sonnweber T, Pizzini A, Tymoszuk P, Scherfler C, Djamshidian A, Kiechl S, Tancevski I, Seppi K, Pfausler B, Loeffler-Ragg J, Helbok R. Factors associated with impaired quality of life three months after being diagnosed with COVID-19. Qual Life Res 2021. [PMID: 34580823 DOI: 10.1007/s11136-021-02998-9] [Reference Citation Analysis]
106 Kyzar EJ, Purpura LJ, Shah J, Cantos A, Nordvig AS, Yin MT. Anxiety, depression, insomnia, and trauma-related symptoms following COVID-19 infection at long-term follow-up. Brain Behav Immun Health 2021;16:100315. [PMID: 34345869 DOI: 10.1016/j.bbih.2021.100315] [Reference Citation Analysis]
107 Patel SK, Torous J. Exploring the Neuropsychiatric Sequalae of Perceived COVID-19 Exposure in College Students: A Pilot Digital Phenotyping Study. Front Psychiatry 2021;12:788926. [PMID: 35082701 DOI: 10.3389/fpsyt.2021.788926] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Schilling C, Meyer-Lindenberg A, Schweiger JI. [Cognitive disorders and sleep disturbances in long COVID]. Nervenarzt 2022. [PMID: 35576015 DOI: 10.1007/s00115-022-01297-z] [Reference Citation Analysis]
109 Pappa S, Barmparessou Z, Athanasiou N, Sakka E, Eleftheriou K, Patrinos S, Sakkas N, Pappas A, Kalomenidis I, Katsaounou P. Depression, Insomnia and Post-Traumatic Stress Disorder in COVID-19 Survivors: Role of Gender and Impact on Quality of Life. JPM 2022;12:486. [DOI: 10.3390/jpm12030486] [Reference Citation Analysis]
110 Mentis AA. What neurological and psychiatric effects does COVID-19 have on its survivors? BMC Med 2021;19:107. [PMID: 33910589 DOI: 10.1186/s12916-021-01986-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Kozato N, Mishra M, Firdosi M. New-onset psychosis due to COVID-19. BMJ Case Rep 2021;14:e242538. [PMID: 33906867 DOI: 10.1136/bcr-2021-242538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
112 Dash S, Dash C, Pandhare J. Therapeutic Significance of microRNA-Mediated Regulation of PARP-1 in SARS-CoV-2 Infection. Noncoding RNA 2021;7:60. [PMID: 34698261 DOI: 10.3390/ncrna7040060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Satheesh NJ, Salloum-Asfar S, Abdulla SA. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report. Viruses 2021;13:2091. [PMID: 34696521 DOI: 10.3390/v13102091] [Reference Citation Analysis]
114 Klaser K, Thompson EJ, Nguyen LH, Sudre CH, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Kerfoot E, Chen L, Deng J, May A, Hu C, Guest A, Selvachandran S, Drew DA, Modat M, Chan AT, Wolf J, Spector TD, Hammers A, Duncan EL, Ourselin S, Steves CJ. Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app. medRxiv 2021:2021. [PMID: 34268526 DOI: 10.1101/2021.07.07.21260137] [Reference Citation Analysis]
115 Tarantino S, Graziano S, Carducci C, Giampaolo R, Grimaldi Capitello T. Cognitive Difficulties, Psychological Symptoms, and Long Lasting Somatic Complaints in Adolescents with Previous SARS-CoV-2 Infection: A Telehealth Cross-Sectional Pilot Study. Brain Sciences 2022;12:969. [DOI: 10.3390/brainsci12080969] [Reference Citation Analysis]
116 De Picker LJ. The future of immunopsychiatry: Three milestones to clinical innovation. Brain Behav Immun Health 2021;16:100314. [PMID: 34589805 DOI: 10.1016/j.bbih.2021.100314] [Reference Citation Analysis]
117 Ignatova D, Krasteva K, Akabalieva K, Alexiev S. Post-COVID-19 psychosis: Cotard's syndrome and potentially high risk of harm and self-harm in a first-onset acute and transient psychotic disorder after resolution of COVID-19 pneumonia. Early Interv Psychiatry 2021. [PMID: 34796667 DOI: 10.1111/eip.13254] [Reference Citation Analysis]
118 Enner S, Shah YD, Ali A, Cerise JE, Esposito J, Rubin L, Subramony A, Kothare S. Patients Diagnosed with Multisystem Inflammatory Syndrome in Children Have Persistent Neurologic, Sleep, and Psychiatric Symptoms After Hospitalization. J Child Neurol. [DOI: 10.1177/08830738221075924] [Reference Citation Analysis]
119 Radfar A, Ferreira MM, Sosa JP, Filip I. Emergent Crisis of COVID-19 Pandemic: Mental Health Challenges and Opportunities. Front Psychiatry 2021;12:631008. [PMID: 34349675 DOI: 10.3389/fpsyt.2021.631008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Kitchen LC, Berman M, Halper J, Chazot P. Rationale for 1068 nm Photobiomodulation Therapy (PBMT) as a Novel, Non-Invasive Treatment for COVID-19 and Other Coronaviruses: Roles of NO and Hsp70. IJMS 2022;23:5221. [DOI: 10.3390/ijms23095221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Hoffer EP. Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers? Am J Med 2021;134:1310-1. [PMID: 34237305 DOI: 10.1016/j.amjmed.2021.05.023] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
122 Nabizadeh F, Seyedalhosseini Z, Balabandian M, Reza Rostami M. Psychological outcomes of the COVID-19 pandemic in patients with Parkinson's disease: A systematic review. J Clin Neurosci 2022;102:101-8. [PMID: 35777112 DOI: 10.1016/j.jocn.2022.06.017] [Reference Citation Analysis]
123 Doughty K, Hu H, Smit J. Therapeutic landscapes during the COVID-19 pandemic: increased and intensified interactions with nature. Social & Cultural Geography. [DOI: 10.1080/14649365.2022.2052168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Kapnick SM. The Nanoparticle-Enabled Success of COVID-19 mRNA Vaccines and the Promise of Microneedle Platforms for Pandemic Vaccine Response. DNA Cell Biol 2021. [PMID: 34958232 DOI: 10.1089/dna.2021.0538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Mathern R, Senthil P, Vu N, Thiyagarajan T. Neurocognitive Rehabilitation in COVID-19 Patients: A Clinical Review. South Med J 2022;115:227-31. [PMID: 35237843 DOI: 10.14423/SMJ.0000000000001371] [Reference Citation Analysis]
126 Håkansson A, Cronhjort M, Lidin-darlington P, Lilja G, Nilsson A, Schandl A, Friberg H. Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19: Protocol for a Pilot Randomized Controlled Trial. Front Psychiatry 2022;13:907215. [DOI: 10.3389/fpsyt.2022.907215] [Reference Citation Analysis]
127 Wen D, Xu J, Wu Z, Liu Y, Zhou Y, Li J, Wang S, Dong X, Saripan MI, Song H. The Effective Cognitive Assessment and Training Methods for COVID-19 Patients With Cognitive Impairment. Front Aging Neurosci 2022;13:827273. [DOI: 10.3389/fnagi.2021.827273] [Reference Citation Analysis]
128 Sampaio Rocha-Filho PA, Magalhães JE, Fernandes Silva D, Carvalho Soares M, Marenga Arruda Buarque L, Dandara Pereira Gama M, Oliveira FAA. Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study. Acta Neurol Belg 2022;122:725-33. [PMID: 35060095 DOI: 10.1007/s13760-021-01851-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 MacIntosh BJ, Ji X, Chen JJ, Gilboa A, Roudaia E, Sekuler AB, Gao F, Chad JA, Jegatheesan A, Masellis M, Goubran M, Rabin J, Lam B, Cheng I, Fowler R, Heyn C, Black SE, Graham SJ. Brain structure and function in people recovering from COVID-19 after hospital discharge or self-isolation: a longitudinal observational study protocol. CMAJ Open 2021;9:E1114-9. [PMID: 34848552 DOI: 10.9778/cmajo.20210023] [Reference Citation Analysis]
130 Haddad PM, Alabdulla M, Latoo J, Iqbal Y. Delirious mania in a patient with COVID-19 pneumonia. BMJ Case Rep 2021;14:e243816. [PMID: 34725060 DOI: 10.1136/bcr-2021-243816] [Reference Citation Analysis]
131 Coleman B, Casiraghi E, Blau H, Chan L, Haendel MA, Laraway B, Callahan TJ, Deer RR, Wilkins KJ, Reese J, Robinson PN. Risk of new-onset psychiatric sequelae of COVID-19 in the early and late post-acute phase. World Psychiatry 2022;21:319-20. [PMID: 35524622 DOI: 10.1002/wps.20992] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Park HY, Song IA, Lee SH, Sim MY, Oh HS, Song KH, Yu ES, Park HY, Oh TK. Prevalence of mental illness among COVID-19 survivors in South Korea: nationwide cohort. BJPsych Open 2021;7:e183. [PMID: 34659793 DOI: 10.1192/bjo.2021.1001] [Reference Citation Analysis]
133 Lyra e Silva NM, Barros-aragão FG, De Felice FG, Ferreira ST. Inflammation at the crossroads of COVID-19, cognitive deficits and depression. Neuropharmacology 2022;209:109023. [DOI: 10.1016/j.neuropharm.2022.109023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. Neuropsychiatric disorders and COVID-19 - Authors' reply. Lancet Psychiatry 2021;8:565-6. [PMID: 34147175 DOI: 10.1016/S2215-0366(21)00202-9] [Reference Citation Analysis]
135 LaVergne SM, Stromberg S, Baxter BA, Webb TL, Dutt TS, Berry K, Tipton M, Haberman J, Massey BR, McFann K, Alnachoukati O, Zier L, Heacock T, Ebel GD, Henao-Tamayo M, Dunn J, Ryan EP. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect Dis 2021;21:677. [PMID: 34256735 DOI: 10.1186/s12879-021-06359-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Ardestani Zadeh A, Arab D. COVID-19 and male reproductive system: pathogenic features and possible mechanisms. J Mol Histol 2021. [PMID: 34232425 DOI: 10.1007/s10735-021-10003-3] [Reference Citation Analysis]
137 Le TT, Gutiérrez-Sacristán A, Son J, Hong C, South AM, Beaulieu-Jones BK, Loh NHW, Luo Y, Morris M, Ngiam KY, Patel LP, Samayamuthu MJ, Schriver E, Tan ALM, Moore J, Cai T, Omenn GS, Avillach P, Kohane IS, Visweswaran S, Mowery DL, Xia Z; Consortium for Clinical Characterization of COVID-19 by EHR (4CE). Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19. Sci Rep 2021;11:20238. [PMID: 34642371 DOI: 10.1038/s41598-021-99481-9] [Reference Citation Analysis]
138 Jovanoski N, Chen X, Becker U, Zalocusky K, Chawla D, Tsai L, Borm M, Neighbors M, Yau V. Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database. BMJ Open 2021;11:e056284. [PMID: 34893488 DOI: 10.1136/bmjopen-2021-056284] [Reference Citation Analysis]
139 Hok L, Rimac H, Mavri J, Vianello R. COVID-19 infection and neurodegeneration: Computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.02.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
140 Boaventura P, Macedo S, Ribeiro F, Jaconiano S, Soares P. Post-COVID-19 Condition: Where Are We Now? Life 2022;12:517. [DOI: 10.3390/life12040517] [Reference Citation Analysis]
141 Thiele I, Fleming RMT. Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replication. Comput Struct Biotechnol J 2022. [PMID: 35874091 DOI: 10.1016/j.csbj.2022.07.019] [Reference Citation Analysis]
142 Katz DL. Knowing Well, Being Well: well-being born of understanding. Am J Health Promot 2021;:8901171211063998. [PMID: 34958285 DOI: 10.1177/08901171211063998] [Reference Citation Analysis]
143 Dąbrowska E, Galińska-Skok B, Waszkiewicz N. Depressive and Neurocognitive Disorders in the Context of the Inflammatory Background of COVID-19. Life (Basel) 2021;11:1056. [PMID: 34685427 DOI: 10.3390/life11101056] [Reference Citation Analysis]
144 Paul E, Fancourt D. Factors influencing self-harm thoughts and behaviours over the first year of the COVID-19 pandemic in the UK: longitudinal analysis of 49 324 adults. Br J Psychiatry 2022;220:31-7. [DOI: 10.1192/bjp.2021.130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
145 Li D, Wang Q, Jia C, Lv Z, Yang J. An Overview of Neurological and Psychiatric Complications During Post-COVID Period: A Narrative Review. JIR 2022;Volume 15:4199-215. [DOI: 10.2147/jir.s375494] [Reference Citation Analysis]
146 Gusdon AM, Faraday N, Aita JS, Kumar S, Mehta I, Choi HA, Cleland JL, Robinson K, McCullough LD, Ng DK, Kannan RM, Kannan S. Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Sci Transl Med 2022;14:eabo2652. [PMID: 35857827 DOI: 10.1126/scitranslmed.abo2652] [Reference Citation Analysis]
147 Palladini M, Bravi B, Colombo F, Caselani E, Di Pasquasio C, D'Orsi G, Rovere-Querini P, Poletti S, Benedetti F, Mazza MG. Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: A proof-of-concept study. Neuropsychol Rehabil 2022;:1-18. [PMID: 35583357 DOI: 10.1080/09602011.2022.2075016] [Reference Citation Analysis]
148 De Picker LJ, Leboyer M, Geddes JR, Morrens M, Harrison PJ, Taquet M. Association between serum lithium level and incidence of COVID-19 infection. Br J Psychiatry 2022;:1-3. [PMID: 35318909 DOI: 10.1192/bjp.2022.42] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Gimbrone C, Rutherford C, Kandula S, Martínez-Alés G, Shaman J, Olfson M, Gould MS, Pei S, Galanti M, Keyes KM. Associations between COVID-19 mobility restrictions and economic, mental health, and suicide-related concerns in the US using cellular phone GPS and Google search volume data. PLoS One 2021;16:e0260931. [PMID: 34936666 DOI: 10.1371/journal.pone.0260931] [Reference Citation Analysis]
150 da Silva Lopes L, Silva RO, de Sousa Lima G, de Araújo Costa AC, Barros DF, Silva-Néto RP. Is there a common pathophysiological mechanism between COVID-19 and depression? Acta Neurol Belg 2021;121:1117-22. [PMID: 34327666 DOI: 10.1007/s13760-021-01748-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
151 Esther van der Schaaf M. The challenges of studying immune-related psychopathologies: What can we learn from individual differences in acute sickness response? Brain Behav Immun 2021;100:309-10. [PMID: 34923108 DOI: 10.1016/j.bbi.2021.12.012] [Reference Citation Analysis]
152 Khanna A, Jones GB. Envisioning Post-pandemic Digital Neurological, Psychiatric and Mental Health Care. Front Digit Health 2021;3:803315. [PMID: 34993505 DOI: 10.3389/fdgth.2021.803315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 Banerjee D, Mukhopadhyay S, Sahana Asmeen M, Javed A. COVID-19 Vaccination: crucial roles and opportunities for the mental health professionals. Glob Ment Health (Camb) 2021;8:e25. [PMID: 34258020 DOI: 10.1017/gmh.2021.25] [Reference Citation Analysis]
154 Khubchandani J, Price JH, Sharma S, Wiblishauser MJ, Webb FJ. COVID-19 infection survivors and the risk of depression and anxiety symptoms: A nationwide study of adults in the United States. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.01.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Czeisler MÉ, Drane A, Winnay SS, Capodilupo ER, Czeisler CA, Rajaratnam SM, Howard ME. Mental health, substance use, and suicidal ideation among unpaid caregivers of adults in the United States during the COVID-19 pandemic: Relationships to age, race/ethnicity, employment, and caregiver intensity. J Affect Disord 2021;295:1259-68. [PMID: 34706440 DOI: 10.1016/j.jad.2021.08.130] [Reference Citation Analysis]
156 Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A, Fleischmann-Struzek C, Heutelbeck A, Katzer K, Mutschke S, Pletz MW, Quickert S, Reinhart K, Stallmach Z, Walter M, Scherag A, Reuken PA. Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection 2022. [PMID: 34997542 DOI: 10.1007/s15010-021-01733-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
157 Yong SJ, Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev Med Virol 2021;:e2315. [PMID: 34888989 DOI: 10.1002/rmv.2315] [Reference Citation Analysis]
158 Nowakowski S, Kokonda M, Sultana R, Duong BB, Nagy SE, Zaidan MF, Baig MM, Grigg BV, Seashore J, Deer RR. Association between Sleep Quality and Mental Health among Patients at a Post-COVID-19 Recovery Clinic. Brain Sciences 2022;12:586. [DOI: 10.3390/brainsci12050586] [Reference Citation Analysis]
159 Zeng N, Zhao YM, Yan W, Li C, Lu QD, Liu L, Ni SY, Mei H, Yuan K, Shi L, Li P, Fan TT, Yuan JL, Vitiello MV, Kosten T, Kondratiuk AL, Sun HQ, Tang XD, Liu MY, Lalvani A, Shi J, Bao YP, Lu L. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry 2022. [PMID: 35668159 DOI: 10.1038/s41380-022-01614-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol 2022. [PMID: 35412072 DOI: 10.1007/s00281-022-00928-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Mahase E. Covid-19: One in three has neurological or psychiatric condition diagnosed after covid infection, study finds. BMJ 2021;373:n908. [PMID: 33827790 DOI: 10.1136/bmj.n908] [Reference Citation Analysis]
162 Etyemez S, Narita Z, Mihaljevic M, Ishizuka K, Kamath V, Yang K, Sawa A. Olfactory dysfunction and face processing of social cognition in first-episode psychosis. Neurosci Res 2021:S0168-0102(21)00211-X. [PMID: 34655664 DOI: 10.1016/j.neures.2021.10.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Cereda G, Ciappolino V, Boscutti A, Cantù F, Enrico P, Oldani L, Delvecchio G, Brambilla P. Zinc as a Neuroprotective Nutrient for COVID-19-Related Neuropsychiatric Manifestations: A Literature Review. Adv Nutr 2022;13:66-79. [PMID: 34634109 DOI: 10.1093/advances/nmab110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
164 Stellema N, Absalom AR. Editorial: Neuroanaesthesiology editorial. Curr Opin Anaesthesiol 2021;34:553-5. [PMID: 34325460 DOI: 10.1097/ACO.0000000000001052] [Reference Citation Analysis]
165 Md Noh MSF, Yusof Khan AHK, Mohd Sabri MN, Kamis MFA, Mohd Yaakob MN, Rahim EA, Muda AS. Vessel wall imaging in COVID-19 associated carotid atherothrombosis and stroke: a case report and literature review. J Cent Nerv Syst Dis 2022;14:11795735221112589. [PMID: 35832610 DOI: 10.1177/11795735221112589] [Reference Citation Analysis]
166 Skyrud KD, Hernæs KH, Telle KE, Magnusson K. Impacts of mild COVID-19 on elevated use of primary and specialist health care services: A nationwide register study from Norway. PLoS One 2021;16:e0257926. [PMID: 34624023 DOI: 10.1371/journal.pone.0257926] [Reference Citation Analysis]
167 Burchill E, Rogers JP, Needham D, Lang AE, Nicholson TR. Neuropsychiatric disorders and COVID-19. Lancet Psychiatry 2021;8:564-5. [PMID: 34147174 DOI: 10.1016/S2215-0366(21)00178-4] [Reference Citation Analysis]
168 Peramo-Álvarez FP, López-Zúñiga MÁ, López-Ruz MÁ. Medical sequels of COVID-19. Med Clin (Engl Ed) 2021;157:388-94. [PMID: 34632064 DOI: 10.1016/j.medcle.2021.04.008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Rivas-Ramírez ÁR, Tendilla-Beltrán H, Gómez-Mendoza LE, Loaiza G, Flores G. Patients with schizophrenia have decreased COVID-19 prevalence among hospitalised patients with psychiatric and neurological diseases: A retrospective analysis in Mexican population. Int J Clin Pract 2021;:e14528. [PMID: 34125988 DOI: 10.1111/ijcp.14528] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Sharma RA, Iosifescu DV. COVID-19 in India: Are we Ready for the Next Crisis? Psychiatric Annals 2021;51:355-355. [DOI: 10.3928/00485713-20210712-01] [Reference Citation Analysis]
171 Liow KK, Viereck J. COVID-19 Is Changing Our Understanding of the Neuroscience of Viral Infections: What We Can Do to Prepare for the Future? Neurology International 2022;14:89-89. [DOI: 10.3390/neurolint14010007] [Reference Citation Analysis]
172 Tran VT, Porcher R, Pane I, Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat Commun 2022;13:1812. [PMID: 35383197 DOI: 10.1038/s41467-022-29513-z] [Cited by in Crossref: 6] [Article Influence: 6.0] [Reference Citation Analysis]
173 Datta G, Miller NM, Halcrow PW, Khan N, Colwell T, Geiger JD, Chen X. SARS-CoV-2 S1 Protein Induces Endolysosome Dysfunction and Neuritic Dystrophy. Front Cell Neurosci 2021;15:777738. [PMID: 34776872 DOI: 10.3389/fncel.2021.777738] [Reference Citation Analysis]
174 Lapin B, Katzan IL. Health-Related Quality of Life Mildly Affected Following COVID-19: a Retrospective Pre-post Cohort Study with a Propensity Score-Matched Control Group. J Gen Intern Med 2022. [PMID: 35025068 DOI: 10.1007/s11606-021-07340-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Ylikoski J, Lehtimäki J, Pääkkönen R, Mäkitie A. Prevention and Treatment of Life-Threatening COVID-19 May Be Possible with Oxygen Treatment. Life 2022;12:754. [DOI: 10.3390/life12050754] [Reference Citation Analysis]
176 Hellwig S, Domschke K. [Post-COVID syndrome-Focus fatigue]. Nervenarzt 2022. [PMID: 35606656 DOI: 10.1007/s00115-022-01306-1] [Reference Citation Analysis]
177 Nikitina AJ, Chimagomedova AS, Levin OS. [Neurological complications of COVID-19 in elderly people]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:5-15. [PMID: 34870908 DOI: 10.17116/jnevro20211211025] [Reference Citation Analysis]
178 Comelli A, Viero G, Bettini G, Nobili A, Tettamanti M, Galbussera AA, Muscatello A, Mantero M, Canetta C, Martinelli Boneschi F, Arighi A, Brambilla P, Vecchi M, Lampertico P, Bonfanti P, Contoli M, Blasi F, Gori A, Bandera A. Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study. Front Med 2022;9:834354. [DOI: 10.3389/fmed.2022.834354] [Reference Citation Analysis]
179 Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med 2021;18:e1003773. [PMID: 34582441 DOI: 10.1371/journal.pmed.1003773] [Cited by in Crossref: 12] [Article Influence: 12.0] [Reference Citation Analysis]
180 Bussière N, Mei J, Lévesque-Boissonneault C, Blais M, Carazo S, Gros-Louis F, De Serres G, Dupré N, Frasnelli J. Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers. Chem Senses 2021;46:bjab038. [PMID: 34423831 DOI: 10.1093/chemse/bjab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Chennapragada L, Sullivan SR, Hamerling-potts KK, Tran H, Szeszko J, Wrobleski J, Mitchell EL, Walsh S, Goodman M. International PRISMA Scoping Review to Understand Mental Health Interventions for Depression in COVID-19 Patients. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114748] [Reference Citation Analysis]
182 Nezgovorova V, Ferretti CJ, Pallanti S, Hollander E. Modulating neuroinflammation in COVID-19 patients with obsessive-compulsive disorder. J Psychiatr Res 2021:S0022-3956(21)00674-9. [PMID: 34809994 DOI: 10.1016/j.jpsychires.2021.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
183 Taquet M, Harrison PJ. Restricting the spread of SARS-CoV-2 or safeguarding mental health: a false dichotomy? The Lancet Public Health 2022. [DOI: 10.1016/s2468-2667(22)00091-3] [Reference Citation Analysis]
184 Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun 2022;103:154-62. [PMID: 35447302 DOI: 10.1016/j.bbi.2022.04.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 15.0] [Reference Citation Analysis]
185 Nersesjan V, Fonsmark L, Christensen RHB, Amiri M, Merie C, Lebech AM, Katzenstein T, Bang LE, Kjærgaard J, Kondziella D, Benros ME. Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non-COVID-19 Illness. JAMA Psychiatry 2022. [PMID: 35319743 DOI: 10.1001/jamapsychiatry.2022.0284] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
186 Tirozzi A, Santonastaso F, de Gaetano G, Iacoviello L, Gialluisi A. Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach. World J Psychiatry 2022; 12(3): 536-540 [PMID: 35433322 DOI: 10.5498/wjp.v12.i3.536] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Chen Y, Zhang N, Zhang J, Guo J, Dong S, Sun H, Gao S, Zhou T, Li M, Liu X, Guo Y, Ye B, Zhao Y, Yu T, Zhan J, Jiang Y, Wong CCL, Gao GF, Liu WJ. Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19. Biochim Biophys Acta Proteins Proteom 2021;1870:140736. [PMID: 34774760 DOI: 10.1016/j.bbapap.2021.140736] [Reference Citation Analysis]
188 Khoreva MA. [Postcovid syndrome - a new reality]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:131-7. [PMID: 34874668 DOI: 10.17116/jnevro2021121101131] [Reference Citation Analysis]
189 Kollins SH. Editorial: The gathering storm: a US perspective on the scientific response to the COVID-19 child and adolescent mental health crisis. J Child Psychol Psychiatry 2022;63:129-31. [PMID: 35165904 DOI: 10.1111/jcpp.13576] [Reference Citation Analysis]
190 Hoertel N, Sánchez-Rico M, Muela P, Abellán M, Blanco C, Leboyer M, Cougoule C, Gulbins E, Kornhuber J, Carpinteiro A, Becker KA, Vernet R, Beeker N, Neuraz A, Alvarado JM, Herrera-Morueco JJ, Airagnes G, Lemogne C, Limosin F; AP-HP / Université de Paris / INSERM COVID-19 research collaboration and AP-HP COVID CDR Initiative, “Entrepôt de Données de Santé” AP-HP Consortium. Risk of death in individuals hospitalized for COVID-19 with and without psychiatric disorders: an observational multicenter study in France. Biol Psychiatry Glob Open Sci 2022. [PMID: 35013734 DOI: 10.1016/j.bpsgos.2021.12.007] [Reference Citation Analysis]
191 Li C, Liu J, Lin J, Shang H. COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study. Transl Psychiatry 2022;12:283. [PMID: 35835752 DOI: 10.1038/s41398-022-02052-3] [Reference Citation Analysis]
192 Verde F, Milone I, Bulgarelli I, Peverelli S, Colombrita C, Maranzano A, Calcagno N, Ticozzi N, Perego GB, Parati G, Torresani E, Ratti A, Silani V. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations. J Neurol 2022. [PMID: 35781535 DOI: 10.1007/s00415-022-11233-5] [Reference Citation Analysis]
193 Ceballos-Baumann A. [Parkinson's Disease - What is New?]. Dtsch Med Wochenschr 2022;147:337-43. [PMID: 35291040 DOI: 10.1055/a-1646-6321] [Reference Citation Analysis]
194 Kahwagi J, Seye AO, Mbodji AB, Diagne R, Mbengue EH, Fall M, Andriamandimby SF, Easton A, Faye M, Fall G, Dia N, Ndiaye B, Ndiaye MB, Gueye A, Mbacke SS, Kane F, Ghouriechy MI, Seck LB, Gaye NM, Sall AA, Ndiaye M, Faye O, Diop AG, Heraud J; ENSENE Investigators. Surveillance of Viral Encephalitis in the Context of COVID-19: A One-Year Observational Study among Hospitalized Patients in Dakar, Senegal. Viruses 2022;14:871. [DOI: 10.3390/v14050871] [Reference Citation Analysis]
195 Bungenberg J, Humkamp K, Hohenfeld C, Rust MI, Ermis U, Dreher M, Hartmann NK, Marx G, Binkofski F, Finke C, Schulz JB, Costa AS, Reetz K. Long COVID‐19: Objectifying most self‐reported neurological symptoms. Ann Clin Transl Neurol. [DOI: 10.1002/acn3.51496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
196 Radan M, Djikic T, Nikolic K. Discovery of new chemotypes of dual 5-HT2A/D2 receptor antagonists with a strategy of drug design methodologies. Future Med Chem 2022;14:963-89. [PMID: 35674007 DOI: 10.4155/fmc-2021-0340] [Reference Citation Analysis]
197 Orendáčová M, Kvašňák E. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Front Public Health 2022;10:903568. [DOI: 10.3389/fpubh.2022.903568] [Reference Citation Analysis]
198 Kelleni MT. COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators. Immunol Res 2021. [PMID: 34357535 DOI: 10.1007/s12026-021-09219-y] [Reference Citation Analysis]
199 Hejbøl EK, Harbo T, Agergaard J, Madsen LB, Pedersen TH, Østergaard LJ, Andersen H, Schrøder HD, Tankisi H. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: Evidence of skeletal muscle histopathology. Eur J Neurol 2022. [PMID: 35661354 DOI: 10.1111/ene.15435] [Reference Citation Analysis]
200 Zheng C, Yi P, Shen G, Chen W. Effects of School Resumption on College Students' Mental Health During the COVID-19 Pandemic. J Psychosoc Nurs Ment Health Serv 2021;:1-9. [PMID: 34846227 DOI: 10.3928/02793695-20211118-02] [Reference Citation Analysis]
201 Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw Open 2021;4:e2128568. [PMID: 34643720 DOI: 10.1001/jamanetworkopen.2021.28568] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
202 Łoś K, Kulikowska J, Waszkiewicz N. The Impact of the COVID-19 Virus Pandemic on the Incidence of First Psychotic Spectrum Disorders. Int J Environ Res Public Health 2022;19:3781. [PMID: 35409462 DOI: 10.3390/ijerph19073781] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Charlton E, Nainar F, Reyes-Beaman S. Neuropsychiatric disorders and COVID-19. Lancet Psychiatry 2021;8:563. [PMID: 34147172 DOI: 10.1016/S2215-0366(21)00177-2] [Reference Citation Analysis]
204 Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ 2022;376:e068993. [PMID: 35172971 DOI: 10.1136/bmj-2021-068993] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 27.0] [Reference Citation Analysis]
205 Ahmad SA, Mohammed SH, Abdulla BA, Salih BK, Hassan MN, Salih AM, Kakamad FH, Abdullah HO, Hassan HA, Othman S, Sidiq SH. Post COVID – 19 neurological disorders; a single center experience; a case series. Annals of Medicine and Surgery 2022;76:103508. [DOI: 10.1016/j.amsu.2022.103508] [Reference Citation Analysis]
206 Rubiano-buitrago JD, Rahiran-ramírez AF, Peña-vargas DM, Paez-rincon LA, Lozada-martinez ID. Post-COVID 19 neurological syndrome: Are we facing a neuropsychiatric phenotype? Journal of Clinical Neuroscience 2022;97:106-7. [DOI: 10.1016/j.jocn.2022.01.010] [Reference Citation Analysis]
207 Day GS. Measuring the cognitive costs of the COVID-19 pandemic. Mol Neurodegener 2021;16:67. [PMID: 34556131 DOI: 10.1186/s13024-021-00492-x] [Reference Citation Analysis]
208 Łoś K, Kulikowska J, Waszkiewicz N. First-Time Psychotic Symptoms in a Patient After COVID-19 Infection-A Case Report. Front Psychiatry 2021;12:726059. [PMID: 34721104 DOI: 10.3389/fpsyt.2021.726059] [Reference Citation Analysis]
209 Ji Z, Han W, Deng Z, Lu K. Distress, Appraisal, and Coping Among the Frontline Healthcare Provider Redeployed to the Epicenter in China During COVID-19 Pandemic. Front Psychol 2021;12:678369. [PMID: 34393905 DOI: 10.3389/fpsyg.2021.678369] [Reference Citation Analysis]
210 Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev 2022;:103071. [PMID: 35182777 DOI: 10.1016/j.autrev.2022.103071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
211 Esposito S, Principi N, Azzari C, Cardinale F, Di Mauro G, Galli L, Gattinara GC, Fainardi V, Guarino A, Lancella L, Licari A, Mancino E, Marseglia GL, Leonardi S, Nenna R, Zampogna S, Zona S, Staiano A, Midulla F. Italian intersociety consensus on management of long covid in children. Ital J Pediatr 2022;48:42. [PMID: 35264214 DOI: 10.1186/s13052-022-01233-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
212 Xie J, Tian S, Liu J, Cao R, Yue P, Cai X, Shang Q, Yang M, Han L, Zhang D. Dual role of the nasal microbiota in neurological diseases—An unignorable risk factor or a potential therapy carrier. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106189] [Reference Citation Analysis]
213 Jing Y, Wang J, Zhang H, Yang K, Li J, Zhao T, Liu J, Wu J, Chen Y. Alterations of Urinary Microbial Metabolites and Immune Indexes Linked With COVID-19 Infection and Prognosis. Front Immunol 2022;13:841739. [PMID: 35422810 DOI: 10.3389/fimmu.2022.841739] [Reference Citation Analysis]
214 Beauchamp MK, Joshi D, McMillan J, Erbas Oz U, Griffith LE, Basta NE, Kirkland S, Wolfson C, Raina P; Canadian Longitudinal Study on Aging (CLSA) Team. Assessment of Functional Mobility After COVID-19 in Adults Aged 50 Years or Older in the Canadian Longitudinal Study on Aging. JAMA Netw Open 2022;5:e2146168. [PMID: 35019980 DOI: 10.1001/jamanetworkopen.2021.46168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
215 Thye AY, Law JW, Tan LT, Pusparajah P, Ser HL, Thurairajasingam S, Letchumanan V, Lee LH. Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19. Biology (Basel) 2022;11:61. [PMID: 35053059 DOI: 10.3390/biology11010061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
216 Yang CP, Chang CM, Yang CC, Pariante CM, Su KP. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun 2022;103:19-27. [PMID: 35390469 DOI: 10.1016/j.bbi.2022.04.001] [Reference Citation Analysis]
217 Holt LJ, Anselmi D, Gasataya SA. Predictors of Vaccine Hesitancy in College-Attending Emerging Adults: Implications for Public Health Outreach. American Journal of Health Education. [DOI: 10.1080/19325037.2022.2048750] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Daly M, Robinson E. Acute and longer-term psychological distress associated with testing positive for COVID-19: longitudinal evidence from a population-based study of US adults. Psychol Med 2021;:1-8. [PMID: 34308807 DOI: 10.1017/S003329172100324X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
219 Hayhoe BW, Powell RA, Barber S, Nicholls D. Impact of COVID-19 on individuals with multimorbidity in primary care. Br J Gen Pract 2022;72:38-9. [PMID: 34972805 DOI: 10.3399/bjgp22X718229] [Reference Citation Analysis]
220 Finsterer J. Neuropsychiatric disorders and COVID-19. Lancet Psychiatry 2021;8:563-4. [PMID: 34147173 DOI: 10.1016/S2215-0366(21)00172-3] [Reference Citation Analysis]
221 Kverno K. Brain Fog: A Bit of Clarity Regarding Etiology, Prognosis, and Treatment. J Psychosoc Nurs Ment Health Serv 2021;59:9-13. [PMID: 34714198 DOI: 10.3928/02793695-20211013-01] [Reference Citation Analysis]
222 Michael BD, Walton D, Westenberg E, García-azorín D, Singh B, Tamborska AA, Netravathi M, Chomba M, Wood GK, Easton A, Siddiqi OK, Jackson TA, Pollak TA, Nicholson TR, Nair S, Breen G, Prasad K, Thakur KT, Chou SH, Schmutzhard E, Frontera JA, Helbok R, Padovani A, Menon DK, Solomon T, Winkler AS; On behalf of the Global COVID-19 Neuro Research Coalition. Consensus Clinical Guidance for Diagnosis and Management of Adult COVID-19 Encephalopathy Patients. JNP. [DOI: 10.1176/appi.neuropsych.22010002] [Reference Citation Analysis]
223 Townsend L, Dyer AH, McCluskey P, O'Brien K, Dowds J, Laird E, Bannan C, Bourke NM, Ní Cheallaigh C, Byrne DG, Kenny RA. Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection. Nutrients 2021;13:2430. [PMID: 34371940 DOI: 10.3390/nu13072430] [Reference Citation Analysis]
224 Wojtkowska A, Tyburski E, Skalacka K, Gasiorowska A. Perceived Decrease in Workplace Security Since the Beginning of the COVID-19 Pandemic: The Importance of Management Styles and Work-Related Attitudes. Front Psychol 2021;12:635973. [PMID: 34489773 DOI: 10.3389/fpsyg.2021.635973] [Reference Citation Analysis]
225 Hallan DR, Rizk E. Ventriculoperitoneal Shunt and Gastrostomy Tube Placement and Timing: A Database Analysis. Cureus. [DOI: 10.7759/cureus.23776] [Reference Citation Analysis]
226 Mogensen MA, Filippi CG. COVID-19: Subacute to Chronic Neuroimaging Findings. Neuroimaging Clinics of North America 2022. [DOI: 10.1016/j.nic.2022.07.004] [Reference Citation Analysis]
227 Dong JH, Yang C, Ding HQ, Xing PJ, Zhou FY, Tian H, Liu X, Zheng HT, Hu SH, Zhu ZL. Development of a Portable Method for Serum Lithium Measurement Based on Low-Cost Miniaturized Ultrasonic Nebulization Coupled with Atmospheric-Pressure Air-Sustained Discharge. Anal Chem 2021;93:13351-9. [PMID: 34558890 DOI: 10.1021/acs.analchem.1c03133] [Reference Citation Analysis]
228 Ganesh A, Reis IR, Varma M, Patry DG, Cooke LJ. Neurological and Head/Eyes/Ears/Nose/Throat Manifestations of COVID-19: A Systematic Review and Meta-Analysis. Can J Neurol Sci 2021;:1-18. [PMID: 34287109 DOI: 10.1017/cjn.2021.180] [Reference Citation Analysis]
229 Chen H, Zhu Z, Qiu Y, Ge X, Zheng H, Peng Y. Prediction of coronavirus 3C-like protease cleavage sites using machine-learning algorithms. Virol Sin 2022:S1995-820X(22)00070-0. [PMID: 35513273 DOI: 10.1016/j.virs.2022.04.006] [Reference Citation Analysis]
230 Stip E, Arnone D, Abdel Aziz K, Javaid SF. Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties. Mol Psychiatry 2021. [PMID: 34282264 DOI: 10.1038/s41380-021-01222-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
231 Crema A, Furfaro I, Raschellà F, Rossini M, Zajc J, Wiesener C, Baccinelli W, Proserpio D, Augsten A, Immick N, Becker S, Weber M, Schauer T, Krakow K, Gasperini G, Molteni F, Russold MF, Bulgheroni M, Micera S. Reactive Exercises with Interactive Objects: Interim Analysis of a Randomized Trial on Task-Driven NMES Grasp Rehabilitation for Subacute and Early Chronic Stroke Patients. Sensors (Basel) 2021;21:6739. [PMID: 34695957 DOI: 10.3390/s21206739] [Reference Citation Analysis]
232 Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, Corruble E, Beurnier A, Jutant EM, Pham T, Lecoq AL, Papon JF, Figueiredo S, Harrois A, Humbert M, Monnet X; COMEBAC Study Group. Post-acute COVID-19 syndrome. Eur Respir Rev 2022;31:210185. [PMID: 35264409 DOI: 10.1183/16000617.0185-2021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
233 Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection 2022. [PMID: 35489015 DOI: 10.1007/s15010-022-01835-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Cecchetti G, Agosta F, Canu E, Basaia S, Barbieri A, Cardamone R, Bernasconi MP, Castelnovo V, Cividini C, Cursi M, Vabanesi M, Impellizzeri M, Lazzarin SM, Fanelli GF, Minicucci F, Giacalone G, Falini A, Falautano M, Rovere-querini P, Roveri L, Filippi M. Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study. J Neurol. [DOI: 10.1007/s00415-022-11047-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Maleitzke T, Zocholl D, Topp T, Dimitrov-discher A, Daus E, Reaux G, Zocholl M, Conze RN, Kolster M, Weber P, Fleckenstein FN, Scheutz Henriksen L, Stöckle U, Fuchs T, Gümbel D, Spranger N, Ringk A, Märdian S. Quality and quantity of serious violent suicide attempts during the COVID-19 pandemic. Front Psychiatry 2022;13:927696. [DOI: 10.3389/fpsyt.2022.927696] [Reference Citation Analysis]
236 Zariffeh A, Youssef AS, Rizvi F, Lew LQ. Post Severe Acute Respiratory Syndrome Coronavirus 2 Infection Tremors in a Nonverbal Autistic Adolescent. Cureus 2021;13:e16296. [PMID: 34405062 DOI: 10.7759/cureus.16296] [Reference Citation Analysis]
237 Martelletti P, Bentivegna E, Spuntarelli V, Luciani M. Long-COVID Headache. SN Compr Clin Med 2021;:1-3. [PMID: 34036244 DOI: 10.1007/s42399-021-00964-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
238 Peluso MJ, Hellmuth J, Chow FC. Central Nervous System Effects of COVID-19 in People with HIV Infection. Curr HIV/AIDS Rep 2021;18:538-48. [PMID: 34843065 DOI: 10.1007/s11904-021-00582-x] [Reference Citation Analysis]
239 Syunyakov TS, Sharaev MG, Savilov VB, Karpenko OA, Kurmyshev MV, Yarkin VE, Ushakov VL, Bibyaev AN, Soloveva KP, Andruschenko AV. A Comparison of Regional Brain Volumes in Older Adults With and Without History of COVID-19. Consortium Psychiatricum 2022;3:76-87. [DOI: 10.17816/cp145] [Reference Citation Analysis]
240 Zangani C, Ostinelli EG, Smith KA, Hong JS, Macdonald O, Reen G, Reid K, Vincent C, Sheriff R, Harrison PJ, Hawton K, Pitman A, Bale R, Fazel S, Geddes JR, Cipriani A. Impact of the COVID-19 pandemic on the global delivery of mental health services and tele-mental health: a systematic review (Preprint). JMIR Mental Health. [DOI: 10.2196/38600] [Reference Citation Analysis]
241 McFann K, Baxter BA, LaVergne SM, Stromberg S, Berry K, Tipton M, Haberman J, Ladd J, Webb TL, Dunn JA, Ryan EP. Quality of Life (QoL) Is Reduced in Those with Severe COVID-19 Disease, Post-Acute Sequelae of COVID-19, and Hospitalization in United States Adults from Northern Colorado. Int J Environ Res Public Health 2021;18:11048. [PMID: 34769566 DOI: 10.3390/ijerph182111048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Whiteside DM, Basso MR, Naini SM, Porter J, Holker E, Waldron EJ, Melnik TE, Niskanen N, Taylor SE. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning. Clin Neuropsychol 2022;:1-23. [PMID: 35130818 DOI: 10.1080/13854046.2022.2030412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
243 Li P, Zhao W, Kaatz S, Latack K, Schultz L, Poisson L. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19. JAMA Netw Open 2021;4:e2135397. [PMID: 34807256 DOI: 10.1001/jamanetworkopen.2021.35397] [Reference Citation Analysis]
244 Saha P, Bose S, Srivastava AK, Chaudhary AA, Lall R, Prasad S. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules 2021;26:6783. [PMID: 34833873 DOI: 10.3390/molecules26226783] [Reference Citation Analysis]
245 Angeles MR, Wanni Arachchige Dona S, Nguyen HD, Le LK, Hensher M. Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan. BMC Public Health 2022;22. [DOI: 10.1186/s12889-022-13169-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Mińko A, Turoń-skrzypińska A, Rył A, Tomska N, Bereda Z, Rotter I. Searching for Factors Influencing the Severity of the Symptoms of Long COVID. IJERPH 2022;19:8013. [DOI: 10.3390/ijerph19138013] [Reference Citation Analysis]
247 Callan C, Ladds E, Husain L, Pattinson K, Greenhalgh T. 'I can't cope with multiple inputs': a qualitative study of the lived experience of 'brain fog' after COVID-19. BMJ Open 2022;12:e056366. [PMID: 35149572 DOI: 10.1136/bmjopen-2021-056366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
248 ElTohamy A, Hyun S, Macaranas AR, Chen JA, Stevens C, Liu CH. Testing positive, losing a loved one, and financial hardship: Real-world impacts of COVID-19 on US college student distress. J Affect Disord 2022;314:357-64. [PMID: 35878829 DOI: 10.1016/j.jad.2022.07.022] [Reference Citation Analysis]
249 Ivanovic J, Stojanovic M, Ristic A, Sokic D, Vojvodic N. Post-acute COVID-19 syndrome presented as a cerebral and systemic vasculitis: a case report. Acta Neurol Belg 2022. [PMID: 35279794 DOI: 10.1007/s13760-022-01923-2] [Reference Citation Analysis]
250 Nataf S, Pays L. Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis. Int J Mol Sci 2021;22:10440. [PMID: 34638785 DOI: 10.3390/ijms221910440] [Reference Citation Analysis]
251 Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho S. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Journal of the Neurological Sciences 2022. [DOI: 10.1016/j.jns.2022.120162] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 30.0] [Reference Citation Analysis]
252 Muir KW, Perry RJ. The International Cerebral Venous Thrombosis Consortium report on cerebral venous thrombosis following vaccination against SARS-CoV-2. Eur J Neurol 2021;28:3543-4. [PMID: 34462996 DOI: 10.1111/ene.15085] [Reference Citation Analysis]
253 Vuorio A, Bor R. Self-Harm in Aviation Medicine-A Complex Challenge During a Pandemic. Front Public Health 2021;9:681618. [PMID: 34409006 DOI: 10.3389/fpubh.2021.681618] [Reference Citation Analysis]
254 Clift AK, Ranger TA, Patone M, Coupland CAC, Hatch R, Thomas K, Hippisley-Cox J, Watkinson P. Neuropsychiatric Ramifications of Severe COVID-19 and Other Severe Acute Respiratory Infections. JAMA Psychiatry 2022. [PMID: 35544272 DOI: 10.1001/jamapsychiatry.2022.1067] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
255 Czeisler MÉ, Wiley JF, Czeisler CA, Rajaratnam SMW, Howard ME. Uncovering survivorship bias in longitudinal mental health surveys during the COVID-19 pandemic. Epidemiol Psychiatr Sci 2021;30:e45. [PMID: 34036933 DOI: 10.1017/S204579602100038X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
256 Camacho RC, Alabed S, Zhou H, Chang SL. Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection. J Neuroimmune Pharmacol 2021. [PMID: 34757528 DOI: 10.1007/s11481-021-10012-9] [Reference Citation Analysis]
257 Freudenberg-hua Y, Makhnevich A, Li W, Liu Y, Qiu M, Marziliano A, Carney M, Greenwald B, Kane JM, Diefenbach M, Burns E, Koppel J, Sinvani L. Psychotropic Medication Use Is Associated With Greater 1-Year Incidence of Dementia After COVID-19 Hospitalization. Front Med 2022;9:841326. [DOI: 10.3389/fmed.2022.841326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
258 Bukhbinder AS, Ling Y, Hasan O, Jiang X, Kim Y, Phelps KN, Schmandt RE, Amran A, Coburn R, Ramesh S, Xiao Q, Schulz PE. Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching. J Alzheimers Dis 2022. [PMID: 35723106 DOI: 10.3233/JAD-220361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
259 Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, Puhan MA. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. PLoS One 2021;16:e0254523. [PMID: 34252157 DOI: 10.1371/journal.pone.0254523] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
260 Ercegovac M, Asanin M, Savic-radojevic A, Ranin J, Matic M, Djukic T, Coric V, Jerotic D, Todorovic N, Milosevic I, Stevanovic G, Simic T, Bukumiric Z, Pljesa-ercegovac M. Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants 2022;11:954. [DOI: 10.3390/antiox11050954] [Reference Citation Analysis]
261 Husain M. COVID and the brain. Brain 2021;144:3545-6. [PMID: 34972206 DOI: 10.1093/brain/awab421] [Reference Citation Analysis]
262 Nelson DW, Granberg T, Andersen P, Jokhadar E, Kåhlin J, Granström A, Hallinder H, Schening A, Thunborg C, Walles H, Hagman G, Shams-Latifi R, Yu J, Petersson S, Tzortzakakis A, Levak N, Aspö M, Piehl F, Zetterberg H, Kivipelto M, Eriksson LI. The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivors. Acta Anaesthesiol Scand 2022. [PMID: 35332517 DOI: 10.1111/aas.14062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Knight DR, Munipalli B, Logvinov II, Halkar MG, Mitri G, Dabrh AMA, Hines SL. Perception, Prevalence, and Prediction of Severe Infection and Post-acute Sequelae of COVID-19. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2022.01.002] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
264 Liu YH, Chen Y, Wang QH, Wang LR, Jiang L, Yang Y, Chen X, Li Y, Cen Y, Xu C, Zhu J, Li W, Wang YR, Zhang LL, Liu J, Xu ZQ, Wang YJ. One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study. JAMA Neurol 2022. [PMID: 35258587 DOI: 10.1001/jamaneurol.2022.0461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 16.0] [Reference Citation Analysis]
265 Hall PA, Sheeran P, Fong GT, Cheah CSL, Oremus M, Liu-Ambrose T, Sakib MN, Butt ZA, Ayaz H, Jandu N, Morita PP. Biobehavioral Aspects of the COVID-19 Pandemic: A Review. Psychosom Med 2021;83:309-21. [PMID: 33790201 DOI: 10.1097/PSY.0000000000000932] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Edlow AG, Castro VM, Shook LL, Kaimal AJ, Perlis RH. Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy. JAMA Netw Open 2022;5:e2215787. [PMID: 35679048 DOI: 10.1001/jamanetworkopen.2022.15787] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
267 Verduzco-Gutierrez M, Estores IM, Graf MJP, Barshikar S, Cabrera JA, Chang LE, Eapen BC, Bell KR. Models of Care for Postacute COVID-19 Clinics: Experiences and a Practical Framework for Outpatient Physiatry Settings. Am J Phys Med Rehabil 2021;100:1133-9. [PMID: 34793373 DOI: 10.1097/PHM.0000000000001892] [Reference Citation Analysis]
268 Taquet M, Geddes JR, Luciano S, Harrison PJ. Incidence and outcomes of eating disorders during the COVID-19 pandemic. Br J Psychiatry. [DOI: 10.1192/bjp.2021.105] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 21.0] [Reference Citation Analysis]
269 van Lith TJ, Sluis WM, Wijers NT, Meijer FJ, Kamphuis-van Ulzen K, de Bresser J, Dankbaar JW, van den Heuvel FM, Antoni ML, Mulders-manders CM, de Mast Q, van de Veerdonk FL, Klok FA, Tuladhar AM, Cannegieter SC, Wermer MJ, van der Worp HB, Huisman MV, de Leeuw F. Prevalence, risk factors, and long-term outcomes of cerebral ischemia in hospitalized COVID-19 patients – study rationale and protocol of the CORONIS study: A multicentre prospective cohort study. European Stroke Journal. [DOI: 10.1177/23969873221092538] [Reference Citation Analysis]
270 Nakamura A, Farrer TJ, Liu A, Simone IL. Long-Term Sequelae in Young Convalescent COVID-19 Patients. Case Reports in Neurological Medicine 2022;2022:1-9. [DOI: 10.1155/2022/9613600] [Reference Citation Analysis]
271 Khwatenge CN, Pate M, Miller LC, Sang Y. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19. Front Immunol 2021;12:732913. [PMID: 34737743 DOI: 10.3389/fimmu.2021.732913] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
272 Chang A, Wang YG, Jayanna MB, Wu X, Cadaret LM, Liu K. Mortality Correlates in Patients With Takotsubo Syndrome During the COVID-19 Pandemic. Mayo Clin Proc Innov Qual Outcomes 2021;5:1050-5. [PMID: 34604705 DOI: 10.1016/j.mayocpiqo.2021.09.008] [Reference Citation Analysis]
273 Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, Heim B, Limmert V, Sahanic S, Pizzini A, Sonnweber T, Tancevski I, Scherfler C, Zamarian L, Bellmann-Weiler R, Weiss G, Djamshidian A, Kiechl S, Seppi K, Loeffler-Ragg J, Pfausler B, Helbok R. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol 2021. [PMID: 33682276 DOI: 10.1111/ene.14803] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
274 Grover S, Sahoo S, Rijal R, Mehra A. Don't forget me in amidst of COVID-19 pandemic: A case series and review of literature on steroid associated psychiatric manifestations. Brain Behav Immun Health 2021;18:100345. [PMID: 34541562 DOI: 10.1016/j.bbih.2021.100345] [Reference Citation Analysis]
275 Matos M, McEwan K, Kanovský M, Halamová J, Steindl SR, Ferreira N, Linharelhos M, Rijo D, Asano K, Márquez MG, Gregório S, Vilas SP, Brito-Pons G, Lucena-Santos P, da Silva Oliveira M, de Souza EL, Llobenes L, Gumiy N, Costa MI, Habib N, Hakem R, Khrad H, Alzahrani A, Cheli S, Petrocchi N, Tholouli E, Issari P, Simos G, Lunding-Gregersen V, Elklit A, Kolts R, Kelly AC, Bortolon C, Delamillieure P, Paucsik M, Wahl JE, Zieba M, Zatorski M, Komendziński T, Zhang S, Basran J, Kagialis A, Kirby J, Gilbert P. Compassion Protects Mental Health and Social Safeness During the COVID-19 Pandemic Across 21 Countries. Mindfulness (N Y) 2022;:1-18. [PMID: 35003380 DOI: 10.1007/s12671-021-01822-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
276 Klaser K, Thompson EJ, Nguyen LH, Sudre CH, Antonelli M, Murray B, Canas LS, Molteni E, Graham MS, Kerfoot E, Chen L, Deng J, May A, Hu C, Guest A, Selvachandran S, Drew DA, Modat M, Chan AT, Wolf J, Spector TD, Hammers A, Duncan EL, Ourselin S, Steves CJ. Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app. J Neurol Neurosurg Psychiatry 2021;92:1254-8. [PMID: 34583944 DOI: 10.1136/jnnp-2021-327565] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Suyanto S, Kandel S, Kemal RA, Arfianti A. The Quality of Life of Coronavirus Disease Survivors Living in Rural and Urban Area of Riau Province, Indonesia. Infectious Disease Reports 2022;14:33-42. [DOI: 10.3390/idr14010005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
278 Liu B, Chang H, Peng K, Wang X. An End-to-End Depression Recognition Method Based on EEGNet. Front Psychiatry 2022;13:864393. [DOI: 10.3389/fpsyt.2022.864393] [Reference Citation Analysis]
279 Almulla AF, Supasitthumrong T, Tunvirachaisakul C, Algon AAA, Al-Hakeim HK, Maes M. The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2022;22:615. [PMID: 35840908 DOI: 10.1186/s12879-022-07582-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Sahoo S, Suman A, Mehra A, Nehra R, Bhalla A, Puri GD, Grover S. Cognitive Deficits in Patients with COVID-19 Infection during Their Hospital Stay: An Exploratory Study. J Neurosci Rural Pract. [DOI: 10.1055/s-0042-1743445] [Reference Citation Analysis]
281 Méndez R, Balanzá-Martínez V, Luperdi SC, Estrada I, Latorre A, González-Jiménez P, Bouzas L, Yépez K, Ferrando A, Reyes S, Menéndez R. Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study. J Intern Med 2021. [PMID: 34569681 DOI: 10.1111/joim.13389] [Reference Citation Analysis]
282 Reeves RR, Willoughby SG. Significant cognitive impairment likely associated with COVID-19 infection with relatively nonsevere symptoms. J Osteopath Med 2022. [PMID: 35073472 DOI: 10.1515/jom-2021-0195] [Reference Citation Analysis]
283 Gan YL, Wang CY, He RH, Hsu PC, Yeh HH, Hsieh TH, Lin HC, Cheng MY, Jeng CJ, Huang MC, Lee YH. FKBP51 mediates resilience to inflammation-induced anxiety through regulation of glutamic acid decarboxylase 65 expression in mouse hippocampus. J Neuroinflammation 2022;19:152. [PMID: 35705957 DOI: 10.1186/s12974-022-02517-8] [Reference Citation Analysis]
284 O'Brien K, Townsend L, Dowds J, Bannan C, Nadarajan P, Kent B, Murphy N, Sheill G, Martin-Loeches I, Guinan E. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study. Respir Res 2022;23:115. [PMID: 35509060 DOI: 10.1186/s12931-022-02032-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Steardo L Jr, Steardo L, Verkhratsky A, Scuderi C. Post-COVID-19 neuropsychiatric syndrome: Is maladaptive glial recovery to blame? Acta Physiol (Oxf) 2021;233:e13717. [PMID: 34264006 DOI: 10.1111/apha.13717] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
286 Cau R, Faa G, Nardi V, Balestrieri A, Puig J, Suri JS, Sanfilippo R, Saba L. Long-COVID diagnosis: from diagnostic to advanced AI-driven models. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
287 Barreira P, Bolotnyy V. A blueprint for measuring and improving graduate student mental health. J Am Coll Health 2022;:1-7. [PMID: 35380928 DOI: 10.1080/07448481.2022.2057804] [Reference Citation Analysis]
288 Manabe T, Heneka MT. Cerebral dysfunctions caused by sepsis during ageing. Nat Rev Immunol 2021. [PMID: 34764472 DOI: 10.1038/s41577-021-00643-7] [Reference Citation Analysis]
289 Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med 2022. [PMID: 35614233 DOI: 10.1038/s41591-022-01840-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 24.0] [Reference Citation Analysis]
290 Günster C, Busse R, Spoden M, Rombey T, Schillinger G, Hoffmann W, Weber-Carstens S, Schuppert A, Karagiannidis C. 6-month mortality and readmissions of hospitalized COVID-19 patients: A nationwide cohort study of 8,679 patients in Germany. PLoS One 2021;16:e0255427. [PMID: 34351975 DOI: 10.1371/journal.pone.0255427] [Reference Citation Analysis]
291 Boyraz RK, Şahan E, Boylu ME, Kırpınar İ. Predictors of long-term anxiety and depression in discharged COVID-19 patients: A follow-up study. World J Clin Cases 2022; 10(22): 7832-7843 [DOI: 10.12998/wjcc.v10.i22.7832] [Reference Citation Analysis]
292 Hingorani KS, Bhadola S, Cervantes-arslanian AM. COVID-19 and the Brain. Trends in Cardiovascular Medicine 2022. [DOI: 10.1016/j.tcm.2022.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
293 Serwin N, Cecerska-Heryć E, Pius-Sadowska E, Serwin K, Niedźwiedź A, Wiśniewska M, Roszak M, Grygorcewicz B, Skwirczyńska E, Machaliński B, Dołęgowska B. Renal and Inflammation Markers-Renalase, Cystatin C, and NGAL Levels in Asymptomatic and Symptomatic SARS-CoV-2 Infection in a One-Month Follow-Up Study. Diagnostics (Basel) 2022;12:108. [PMID: 35054276 DOI: 10.3390/diagnostics12010108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
294 Savarraj JPJ, Burkett AB, Hinds SN, Paz AS, Assing A, Juneja S, Colpo GD, Torres LF, Cho SM, Gusdon AM, McCullough LD, Choi HA. Pain and Other Neurological Symptoms Are Present at 3 Months After Hospitalization in COVID-19 Patients. Front Pain Res (Lausanne) 2021;2:737961. [PMID: 35295410 DOI: 10.3389/fpain.2021.737961] [Reference Citation Analysis]
295 Han Y, Yuan K, Wang Z, Liu WJ, Lu ZA, Liu L, Shi L, Yan W, Yuan JL, Li JL, Shi J, Liu ZC, Wang GH, Kosten T, Bao YP, Lu L. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl Psychiatry 2021;11:499. [PMID: 34593760 DOI: 10.1038/s41398-021-01629-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
296 Telatar TG, Telatar A, Hocaoğlu Ç, Hizal A, Sakin M, Üner S. COVID-19 Survivors' Intensive Care Unit Experiences and Their Possible Effects on Mental Health: A Qualitative Study. J Nerv Ment Dis 2022. [PMID: 35764594 DOI: 10.1097/NMD.0000000000001560] [Reference Citation Analysis]
297 Grabacka M, Pierzchalska M, Płonka PM, Pierzchalski P. The Role of PPAR Alpha in the Modulation of Innate Immunity. Int J Mol Sci 2021;22:10545. [PMID: 34638886 DOI: 10.3390/ijms221910545] [Reference Citation Analysis]
298 Hallan DR, Simion C, Rizk E. Early Versus Late Tracheostomy in Spontaneous Intracerebral Hemorrhage. Cureus. [DOI: 10.7759/cureus.24059] [Reference Citation Analysis]
299 Takata J, Durkin SM, Wong S, Zandi MS, Swanton JK, Corrah TW. A case report of ChAdOx1 nCoV-19 vaccine-associated encephalitis. BMC Neurol 2021;21:485. [PMID: 34903200 DOI: 10.1186/s12883-021-02517-w] [Reference Citation Analysis]
300 Spinney L. Pandemics disable people - the history lesson that policymakers ignore. Nature 2022;602:383-5. [PMID: 35173335 DOI: 10.1038/d41586-022-00414-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
301 Fountoulakis KN, Karakatsoulis GN, Abraham S, Adorjan K, Ahmed HU, Alarcón RD, Arai K, Auwal SS, Berk M, Bjedov S, Bobes J, Bobes-bascaran T, Bourgin-duchesnay J, Bredicean CA, Bukelskis L, Burkadze A, Abud IIC, Castilla-puentes R, Cetkovich M, Colon-rivera H, Corral R, Cortez-vergara C, Crepin P, De Berardis D, Delgado SZ, De Lucena D, De Sousa A, Stefano RD, Dodd S, Elek LP, Elissa A, Erdelyi-hamza B, Erzin G, Etchevers MJ, Falkai P, Farcas A, Fedotov I, Filatova V, Fountoulakis NK, Frankova I, Franza F, Frias P, Galako T, Garay CJ, Garcia-álvarez L, García-portilla MP, Gonda X, Gondek TM, González DM, Gould H, Grandinetti P, Grau A, Groudeva V, Hagin M, Harada T, Hasan TM, Hashim NA, Hilbig J, Hossain S, Iakimova R, Ibrahim M, Iftene F, Ignatenko Y, Irarrazaval M, Ismail Z, Ismayilova J, Jakobs A, Jakovljević M, Jakšić N, Javed A, Kafali HY, Karia S, Kazakova O, Khalifa D, Khaustova O, Koh S, Kopishinskaia S, Kosenko K, Koupidis SA, Kovacs I, Kulig B, Lalljee A, Liewig J, Majid A, Malashonkova E, Malik K, Malik NI, Mammadzada G, Mandalia B, Marazziti D, Marčinko D, Martinez S, Matiekus E, Mejia G, Memon RS, Martínez XEM, Mickevičiūtė D, Milev R, Mohammed M, Molina-lópez A, Morozov P, Muhammad NS, Mustač F, Naor MS, Nassieb A, Navickas A, Okasha T, Pandova M, Panfil A, Panteleeva L, Papava I, Patsali ME, Pavlichenko A, Pejuskovic B, Da Costa MP, Popkov M, Popovic D, Raduan NJN, Ramírez FV, Rancans E, Razali S, Rebok F, Rewekant A, Flores ENR, Rivera-encinas MT, Saiz P, de Carmona MS, Martínez DS, Saw JA, Saygili G, Schneidereit P, Shah B, Shirasaka T, Silagadze K, Sitanggang S, Skugarevsky O, Spikina A, Mahalingappa SS, Stoyanova M, Szczegielniak A, Tamasan SC, Tavormina G, Tavormina MGM, Theodorakis PN, Tohen M, Tsapakis EM, Tukhvatullina D, Ullah I, Vaidya R, Vega-dienstmaier JM, Vrublevska J, Vukovic O, Vysotska O, Widiasih N, Yashikhina A, Prezerakos PE, Smirnova D. The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: data from the international COMET-G study. Psychiatry Research 2022. [DOI: 10.1016/j.psychres.2022.114702] [Reference Citation Analysis]
302 Thurnher MM, Reith W, Thurnher AP, Rommer P. [Long COVID: long-term symptoms and morphological/radiological correlates]. Radiologe 2021;61:915-22. [PMID: 34554270 DOI: 10.1007/s00117-021-00910-7] [Reference Citation Analysis]
303 Castro VM, Rosand J, Giacino JT, McCoy TH, Perlis RH. Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems. Mol Psychiatry 2022. [PMID: 35705635 DOI: 10.1038/s41380-022-01646-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Mendez-Lopez A, Stuckler D, McKee M, Semenza JC, Lazarus JV. The mental health crisis during the COVID-19 pandemic in older adults and the role of physical distancing interventions and social protection measures in 26 European countries. SSM Popul Health 2022;17:101017. [PMID: 34977323 DOI: 10.1016/j.ssmph.2021.101017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
305 Griffanti L, Raman B, Alfaro-Almagro F, Filippini N, Cassar MP, Sheerin F, Okell TW, Kennedy McConnell FA, Chappell MA, Wang C, Arthofer C, Lange FJ, Andersson J, Mackay CE, Tunnicliffe EM, Rowland M, Neubauer S, Miller KL, Jezzard P, Smith SM. Adapting the UK Biobank Brain Imaging Protocol and Analysis Pipeline for the C-MORE Multi-Organ Study of COVID-19 Survivors. Front Neurol 2021;12:753284. [PMID: 34777224 DOI: 10.3389/fneur.2021.753284] [Reference Citation Analysis]
306 Suvvari TK, Kutikuppala LVS, Tsagkaris C, Corriero AC, Kandi V. Post-COVID-19 complications: Multisystemic approach. J Med Virol 2021. [PMID: 34289162 DOI: 10.1002/jmv.27222] [Reference Citation Analysis]
307 Bhola S, Trisal J, Thakur V, Kaur P, Kulshrestha S, Bhatia SK, Kumar P. Neurological toll of COVID-19. Neurol Sci 2022;43:2171-86. [PMID: 35034236 DOI: 10.1007/s10072-022-05875-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
308 Frontera JA, Simon NM. Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19. JAMA Psychiatry 2022. [PMID: 35767287 DOI: 10.1001/jamapsychiatry.2022.1616] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Biancolella M, Colona VL, Mehrian-Shai R, Watt JL, Luzzatto L, Novelli G, Reichardt JKV. COVID-19 2022 update: transition of the pandemic to the endemic phase. Hum Genomics 2022;16:19. [PMID: 35650595 DOI: 10.1186/s40246-022-00392-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
310 Gaffney AW. The Long COVID Conundrum. Am J Med 2022;135:5-6. [PMID: 34428463 DOI: 10.1016/j.amjmed.2021.07.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
311 García-Sánchez C, Calabria M, Grunden N, Pons C, Arroyo JA, Gómez-Anson B, Lleó A, Alcolea D, Belvís R, Morollón N, Mur I, Pomar V, Domingo P. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav 2022;:e2508. [PMID: 35137561 DOI: 10.1002/brb3.2508] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
312 Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, Obeidat M, Obeidat Y, Gerberi D, Taha RM, Kashour Z, Kashour T, Berbari EF, Alkattan K, Tleyjeh IM. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.01.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
313 Wang L, Foer D, MacPhaul E, Lo YC, Bates DW, Zhou L. PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes. J Biomed Inform 2021;125:103951. [PMID: 34785382 DOI: 10.1016/j.jbi.2021.103951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Rivera-Izquierdo M, Láinez-Ramos-Bossini AJ, de Alba IG, Ortiz-González-Serna R, Serrano-Ortiz Á, Fernández-Martínez NF, Ruiz-Montero R, Cervilla JA. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med 2022;20:92. [PMID: 35193574 DOI: 10.1186/s12916-022-02292-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
315 Mazza MG, Palladini M, De Lorenzo R, Bravi B, Poletti S, Furlan R, Ciceri F, Rovere-Querini P, Benedetti F; COVID-19 BioB Outpatient Clinic Study group. One-year mental health outcomes in a cohort of COVID-19 survivors. J Psychiatr Res 2021;145:118-24. [PMID: 34894521 DOI: 10.1016/j.jpsychires.2021.11.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
316 Sandler CX, Wyller VBB, Moss-Morris R, Buchwald D, Crawley E, Hautvast J, Katz BZ, Knoop H, Little P, Taylor R, Wensaas KA, Lloyd AR. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect Dis 2021;8:ofab440. [PMID: 34631916 DOI: 10.1093/ofid/ofab440] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl JP, Yahav D. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect 2022:S1198-743X(22)00092-1. [PMID: 35182760 DOI: 10.1016/j.cmi.2022.02.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
318 Benedetti F, Silvestri G, Mavian C, Weichseldorfer M, Munawwar A, Cash MN, Dulcey M, Vittor AY, Ciccozzi M, Salemi M, Latinovic OS, Zella D. Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells. Viruses 2021;13:2193. [PMID: 34834998 DOI: 10.3390/v13112193] [Reference Citation Analysis]
319 Woodward S, Bari S, Vike N, Lalvani S, Stetsiv K, Kim BW, Stefanopoulos L, Maglaveras N, Breiter H, Katsaggelos A. Anxiety, Post-COVID-Syndrome-related depression, and suicidal thinking and behavior in COVID-19 survivors (Preprint). JMIR Formative Research. [DOI: 10.2196/36656] [Reference Citation Analysis]
320 Ragheb J, McKinney A, Zierau M, Brooks J, Hill-Caruthers M, Iskander M, Ahmed Y, Lobo R, Mentz G, Vlisides PE. Delirium and neuropsychological outcomes in critically Ill patients with COVID-19: a cohort study. BMJ Open 2021;11:e050045. [PMID: 34535480 DOI: 10.1136/bmjopen-2021-050045] [Reference Citation Analysis]
321 López-Atanes M, González-Briceño JP, Abeal-Adham A, Fuertes-Soriano S, Cabezas-Garduño J, Peña-Rotella Á, Sáenz-Herrero M. Liaison Psychiatry During the Peak of the Coronavirus Pandemic: A Description of Referrals and Interventions. Front Psychiatry 2021;12:555080. [PMID: 34955903 DOI: 10.3389/fpsyt.2021.555080] [Reference Citation Analysis]
322 Zhou Y, Xu J, Hou Y, Leverenz JB, Kallianpur A, Mehra R, Liu Y, Yu H, Pieper AA, Jehi L, Cheng F. Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res Ther 2021;13:110. [PMID: 34108016 DOI: 10.1186/s13195-021-00850-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
323 Wichniak A, Kania A, Siemiński M, Cubała WJ. Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders. Int J Mol Sci 2021;22:8623. [PMID: 34445329 DOI: 10.3390/ijms22168623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Makivic N, Stöllberger C, Schauer D, Bernhofer L, Pawelka E, Erfurth A, Weidinger F. Pulmonary Embolism and Acute Psychosis, a Case Report of an Outpatient with a Mild Course of COVID-19. SN Compr Clin Med 2021;:1-6. [PMID: 33937635 DOI: 10.1007/s42399-021-00925-0] [Reference Citation Analysis]
325 Liu L, Ni SY, Yan W, Lu QD, Zhao YM, Xu YY, Mei H, Shi L, Yuan K, Han Y, Deng JH, Sun YK, Meng SQ, Jiang ZD, Zeng N, Que JY, Zheng YB, Yang BN, Gong YM, Ravindran AV, Kosten T, Wing YK, Tang XD, Yuan JL, Wu P, Shi J, Bao YP, Lu L. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action. EClinicalMedicine 2021;40:101111. [PMID: 34514362 DOI: 10.1016/j.eclinm.2021.101111] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Deng Y, Zhao H, Liu Y, Liu H, Shi J, Zhao C, He M. Association of using biomass fuel for cooking with depression and anxiety symptoms in older Chinese adults. Sci Total Environ 2021;811:152256. [PMID: 34896507 DOI: 10.1016/j.scitotenv.2021.152256] [Reference Citation Analysis]
327 Tausch A, E Souza RO, Viciana CM, Cayetano C, Barbosa J, Hennis AJ. Strengthening mental health responses to COVID-19 in the Americas: A health policy analysis and recommendations. Lancet Reg Health Am 2022;5:100118. [PMID: 35098200 DOI: 10.1016/j.lana.2021.100118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
328 Richter D, Zürcher S. [Long Covid/Post Covid - Epidemiology, Possible Causes and Need for Rehabilitation for People with Mental Health Problems]. Psychiatr Prax 2021;48:283-5. [PMID: 34492712 DOI: 10.1055/a-1545-9441] [Reference Citation Analysis]
329 Hernandez-Romieu AC, Carton TW, Saydah S, Azziz-Baumgartner E, Boehmer TK, Garret NY, Bailey LC, Cowell LG, Draper C, Mayer KH, Nagavedu K, Puro JE, Rasmussen SA, Trick WE, Wanga V, Chevinsky JR, Jackson BR, Goodman AB, Cope JR, Gundlapalli AV, Block JP. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2. JAMA Netw Open 2022;5:e2147053. [PMID: 35119459 DOI: 10.1001/jamanetworkopen.2021.47053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Seong M, Park J, Chung S, Sok S. Development of the Adult Pandemic Attitude Scale (A-PAS). Int J Environ Res Public Health 2021;18:6311. [PMID: 34200858 DOI: 10.3390/ijerph18126311] [Reference Citation Analysis]
331 Huang S, Fishell G. In SARS-CoV-2, astrocytes are in it for the long haul. Proc Natl Acad Sci U S A 2022;119:e2209130119. [PMID: 35858460 DOI: 10.1073/pnas.2209130119] [Reference Citation Analysis]
332 Liu N, Tan JS, Liu L, Wang Y, Hua L, Qian Q. Genetic Predisposition Between COVID-19 and Four Mental Illnesses: A Bidirectional, Two-Sample Mendelian Randomization Study. Front Psychiatry 2021;12:746276. [PMID: 34744839 DOI: 10.3389/fpsyt.2021.746276] [Reference Citation Analysis]
333 Zhou C, Li R, Yang M, Duan S, Yang C. Psychological Status of High School Students 1 Year After the COVID-19 Emergency. Front Psychiatry 2021;12:729930. [PMID: 34721106 DOI: 10.3389/fpsyt.2021.729930] [Reference Citation Analysis]
334 Butterworth P, Schurer S, Trinh T, Vera-toscano E, Wooden M. Effect of lockdown on mental health in Australia: evidence from a natural experiment analysing a longitudinal probability sample survey. The Lancet Public Health 2022. [DOI: 10.1016/s2468-2667(22)00082-2] [Reference Citation Analysis]
335 Simon OJ, Menzler K, Timmermann L. [Update 2021: COVID-19 from the perspective of neurology]. Dtsch Med Wochenschr 2021;146:918-23. [PMID: 34256409 DOI: 10.1055/a-1449-5098] [Reference Citation Analysis]
336 Peterson CJ, Sarangi A, Bangash F. Neurological sequelae of COVID-19: a review. Egypt J Neurol Psychiatr Neurosurg 2021;57:122. [PMID: 34511868 DOI: 10.1186/s41983-021-00379-0] [Reference Citation Analysis]
337 Hamilton OS, Cadar D, Steptoe A. Systemic inflammation and emotional responses during the COVID-19 pandemic. Transl Psychiatry 2021;11:626. [PMID: 34887380 DOI: 10.1038/s41398-021-01753-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
338 Berger M, Daubin D, Charriot J, Klouche K, Le Moing V, Arnaud B, Morquin D, Jaussent A, Taourel P, Hayot M, Nagot N, Fesler P, Roubille C. Devenir des patients hospitalisés en soins critiques pour infection à SARS-COV2 : évaluation standardisée des séquelles à 6–9 mois. La Revue de Médecine Interne 2022;43:A113-4. [DOI: 10.1016/j.revmed.2022.03.307] [Reference Citation Analysis]
339 Wong CO, Lung KC, Hui HM, Chung JP. The Prevalence and Clinical Correlates of Psychiatric Morbidities in Adult Chinese COVID-19 Survivors: A Cross-Sectional Study. Asia Pac J Public Health 2022;:10105395221083385. [PMID: 35255736 DOI: 10.1177/10105395221083385] [Reference Citation Analysis]
340 Xu G, Li Y, Zhang S, Peng H, Wang Y, Li D, Jin T, He Z, Tong Y, Qi C, Wu G, Dong K, Gou J, Liu Y, Xiao T, Qu J, Li L, Liu L, Zhao P, Zhang Z, Yuan J. SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation. Cell Res 2021. [PMID: 34663909 DOI: 10.1038/s41422-021-00578-7] [Reference Citation Analysis]
341 Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, Hu P, Guo L, Liu M, Xu J, Zhang X, Qu Y, Fan Y, Li X, Li C, Yu T, Xia J, Wei M, Chen L, Li Y, Xiao F, Liu D, Wang J, Wang X, Cao B. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet 2021;398:747-58. [PMID: 34454673 DOI: 10.1016/S0140-6736(21)01755-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 11.0] [Reference Citation Analysis]
342 Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS Drugs 2022. [PMID: 35727534 DOI: 10.1007/s40263-022-00931-3] [Reference Citation Analysis]
343 Lam SM, Huang X, Shui G. Neurological aspects of SARS-CoV-2 infection: lipoproteins and exosomes as Trojan horses. Trends Endocrinol Metab 2022;33:554-68. [PMID: 35613979 DOI: 10.1016/j.tem.2022.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Lamontagne SJ, Winters MF, Pizzagalli DA, Olmstead MC. Post-acute sequelae of COVID-19: Evidence of mood & cognitive impairment. Brain Behav Immun Health 2021;17:100347. [PMID: 34549199 DOI: 10.1016/j.bbih.2021.100347] [Reference Citation Analysis]
345 Oliu-Barton M, Pradelski BSR, Aghion P, Artus P, Kickbusch I, Lazarus JV, Sridhar D, Vanderslott S. SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties. Lancet 2021;397:2234-6. [PMID: 33932328 DOI: 10.1016/S0140-6736(21)00978-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 19.0] [Reference Citation Analysis]
346 Chauhan S, Meshram HS, Kute V, Patel H, Desai S, Dave R. Long-term follow-up of SARS-CoV-2 recovered renal transplant recipients: A single-center experience from India. Transpl Infect Dis 2021;:e13735. [PMID: 34547156 DOI: 10.1111/tid.13735] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
347 Sajdel-Sulkowska EM. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling. Biomed Res Int 2021;2021:7880448. [PMID: 34651049 DOI: 10.1155/2021/7880448] [Reference Citation Analysis]
348 Efstathiou V, Stefanou MI, Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Spandidos DA, Smyrnis N, Rizos E. Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review). Exp Ther Med 2022;23:107. [PMID: 34976149 DOI: 10.3892/etm.2021.11030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Stanojević M. Neonatal and child mortality - are they different in developing and developed countries? J Perinat Med 2022. [PMID: 35234020 DOI: 10.1515/jpm-2022-0059] [Reference Citation Analysis]
350 Cervantes-arslanian AM, Venkata C, Anand P, Burns JD, Ong CJ, Lemahieu AM, Schulte PJ, Singh TD, Rabinstein AA, Deo N, Bansal V, Boman K, Domecq Garces JP, Lee Armaignac D, Christie AB, Melamed RR, Tarabichi Y, Cheruku SR, Khanna AK, Denson JL, Banner-goodspeed VM, Anderson HL, Gajic O, Kumar VK, Walkey A, Kashyap R; on behalf of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group. Neurologic Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Hospitalized Patients During the First Year of the COVID-19 Pandemic. Critical Care Explorations 2022;4:e0686. [DOI: 10.1097/cce.0000000000000686] [Reference Citation Analysis]
351 Peramo-Álvarez FP, López-Zúñiga MÁ, López-Ruz MÁ. Medical sequels of COVID-19. Med Clin (Barc) 2021:S0025-7753(21)00289-X. [PMID: 34140166 DOI: 10.1016/j.medcli.2021.04.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 de Abreu Costa M, Kristensen CH, Dreher CB, Manfro GG, Salum GA. Habituating to pandemic anxiety: Temporal trends of COVID-19 anxiety over sixteen months of COVID-19. J Affect Disord 2022:S0165-0327(22)00737-6. [PMID: 35772625 DOI: 10.1016/j.jad.2022.06.077] [Reference Citation Analysis]
353 Kelly BD, Gulati G. Long COVID: The Elephant in the Room. QJM 2021:hcab299. [PMID: 34850227 DOI: 10.1093/qjmed/hcab299] [Reference Citation Analysis]
354 van Reekum EA, Rosic T, Sergeant A, Sanger N, Rodrigues M, Rebinsky R, Panesar B, Deck E, Kim N, Woo J, D'Elia A, Hillmer A, Dufort A, Sanger S, Thabane L, Mbuagbaw L, Samaan Z. Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review. J Med Case Rep 2021;15:586. [PMID: 34903299 DOI: 10.1186/s13256-021-03140-6] [Reference Citation Analysis]
355 Larson PS, Bergmans RS. Impact of the COVID-19 pandemic on temporal patterns of mental health and substance abuse related mortality in Michigan: An interrupted time series analysis. Lancet Reg Health Am 2022;10:100218. [PMID: 35284903 DOI: 10.1016/j.lana.2022.100218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Ohira M, Sano T, Takao M. Clinical features of patients who visited the outpatient clinic for long COVID in Japan. eNeurologicalSci 2022;:100418. [PMID: 35919910 DOI: 10.1016/j.ensci.2022.100418] [Reference Citation Analysis]
357 Hornick MG, Olson ME, Jadhav AL. SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies. Int J Neuropsychopharmacol 2021:pyab069. [PMID: 34648616 DOI: 10.1093/ijnp/pyab069] [Reference Citation Analysis]
358 Shields C, Bernard J, Mirza OI, Reeves D, Wells A, Heagerty A. Covid-19, Lockdown and Self-Isolation: Evaluation of Deliberate Self-Harm Admissions. Front Psychiatry 2021;12:662885. [PMID: 34079485 DOI: 10.3389/fpsyt.2021.662885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
359 Gao CC, Li M, Deng W, Ma CH, Chen YS, Sun YQ, Du T, Liu QL, Li WJ, Zhang B, Sun L, Liu SM, Li F, Qi F, Qu Y, Ge X, Liu J, Wang P, Niu Y, Liang Z, Zhao YL, Huang B, Peng XZ, Yang Y, Qin C, Tong WM, Yang YG. Differential transcriptomic landscapes of multiple organs from SARS-CoV-2 early infected rhesus macaques. Protein Cell 2022;13:920-39. [PMID: 35377064 DOI: 10.1007/s13238-022-00915-5] [Reference Citation Analysis]
360 Anand H, Ende V, Singh G, Qureshi I, Duong TQ, Mehler MF. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome. Front Neurosci 2021;15:727060. [PMID: 34512253 DOI: 10.3389/fnins.2021.727060] [Reference Citation Analysis]
361 Viszlayová D, Sojka M, Dobrodenková S, Szabó S, Bilec O, Turzová M, Ďurina J, Baloghová B, Borbély Z, Kršák M. SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID. Ther Adv Infect Dis 2021;8:20499361211048572. [PMID: 34659752 DOI: 10.1177/20499361211048572] [Reference Citation Analysis]
362 Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat Rev Drug Discov 2022. [PMID: 35039676 DOI: 10.1038/s41573-021-00368-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
363 Bhargava A, Zhao W, Sharma M, Szpunar SM, Saravolatz L. Six-Month Post-Acute COVID-19: High Self-Reported Morbidity Among Adults Younger Than Sixty Years and Females. J Clin Med Res 2021;13:567-71. [PMID: 35059076 DOI: 10.14740/jocmr4640] [Reference Citation Analysis]
364 Schneider SA, Hennig A, Martino D. Relationship between COVID-19 and movement disorders: A narrative review. Eur J Neurol 2021. [PMID: 34918437 DOI: 10.1111/ene.15217] [Reference Citation Analysis]
365 Whiteside DM, Naini SM, Basso MR, Waldron EJ, Holker E, Porter J, Niskanen N, Melnik TE, Taylor SE. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection part 2: Psychological functioning. Clin Neuropsychol 2022;:1-19. [PMID: 35098861 DOI: 10.1080/13854046.2022.2030411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Duarte D, El-hagrassy MM, Couto T, Gurgel W, Frey BN, Kapczinski F, Corrêa H. Physician suicide demographics and the COVID-19 pandemic. Braz J Psychiatry. [DOI: 10.1590/1516-4446-2021-1865] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Blackmon K, Day GS, Powers HR, Bosch W, Prabhakaran D, Woolston D, Pedraza O. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage. BMC Neurol 2022;22:285. [PMID: 35907815 DOI: 10.1186/s12883-022-02817-9] [Reference Citation Analysis]
368 Borsche M, Reichel D, Fellbrich A, Lixenfeld AS, Rahmöller J, Vollstedt EJ, Föh B, Balck A, Klein C, Ehlers M, Moser A. Persistent cognitive impairment associated with cerebrospinal fluid anti-SARS-CoV-2 antibodies six months after mild COVID-19. Neurol Res Pract 2021;3:34. [PMID: 34148546 DOI: 10.1186/s42466-021-00135-y] [Reference Citation Analysis]
369 Fond G, Masson M, Lançon C, Richieri R, Guedj E. The neuroinflammatory pathways of post-SARS-CoV-2 psychiatric disorders. Encephale 2021;47:399-400. [PMID: 34593237 DOI: 10.1016/j.encep.2021.08.001] [Reference Citation Analysis]
370 Liu L, Wang X, Hao Y, Yang J, Yang D, Duan X, Fang G, Han B, Jiang C, Li J, Liu Y, Wang Y, Song R. The Gaps Between the Self and Professional Evaluation in Mental Health Assessment of COVID-19 Cluster Cases. Front Psychol 2021;12:614193. [PMID: 34531776 DOI: 10.3389/fpsyg.2021.614193] [Reference Citation Analysis]
371 Murata F, Maeda M, Ishiguro C, Fukuda H. Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data. Gen Psych 2022;35:e100802. [DOI: 10.1136/gpsych-2022-100802] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Krebs NM, D'Souza G, Bordner C, Allen SI, Hobkirk AL, Foulds J, Yingst JM. COVID-19 Vaccination Uptake and Hesitancy Among Current Tobacco Users. Tob Use Insights 2021;14:1179173X211068027. [PMID: 34987300 DOI: 10.1177/1179173X211068027] [Reference Citation Analysis]
373 Colbourne L, Luciano S, Harrison PJ. Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes. Transl Psychiatry 2021;11:319. [PMID: 34039956 DOI: 10.1038/s41398-021-01444-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
374 Mennis J, Matthews KA, Huston SL. Geospatial Perspectives on the Intersection of Chronic Disease and COVID-19. Prev Chronic Dis 2022;19:E39. [PMID: 35772034 DOI: 10.5888/pcd19.220145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
375 Chen S, Han Y, Yang L, Kim T, Nair M, Harschnitz O, Wang P, Zhu J, Koo SY, Tang X, Lacko L, Chandar V, Bram Y, Zhang T, Zhang W, He F, Caicedo J, Huang Y, Evans T, van der Valk P, Titulaer MJ, Spoor JKH, Furler RL, Canoll P, Goldman J, Przedborski S, Schwartz R, Ho D, Studer L. SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence. Res Sq 2021:rs. [PMID: 34031650 DOI: 10.21203/rs.3.rs-513461/v1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
376 Chaudhary AMD, Musavi NB, Saboor S, Javed S, Khan S, Naveed S. Psychosis during the COVID-19 pandemic: A systematic review of case reports and case series. Journal of Psychiatric Research 2022;153:37-55. [DOI: 10.1016/j.jpsychires.2022.06.041] [Reference Citation Analysis]
377 Prokopovich G. Connection of suicidal behavior with COVID-19 (clinical cases). Consortium Psychiatricum. [DOI: 10.17816/cp170] [Reference Citation Analysis]
378 Jonigk D, Werlein C, Acker T, Aepfelbacher M, Amann KU, Baretton G, Barth P, Bohle RM, Büttner A, Büttner R, Dettmeyer R, Eichhorn P, Elezkurtaj S, Esposito I, Evert K, Evert M, Fend F, Gaßler N, Gattenlöhner S, Glatzel M, Göbel H, Gradhand E, Hansen T, Hartmann A, Heinemann A, Heppner FL, Hilsenbeck J, Horst D, Kamp JC, Mall G, Märkl B, Ondruschka B, Pablik J, Pfefferle S, Quaas A, Radbruch H, Röcken C, Rosenwald A, Roth W, Rudelius M, Schirmacher P, Slotta-Huspenina J, Smith K, Sommer L, Stock K, Ströbel P, Strobl S, Titze U, Weirich G, Weis J, Werner M, Wickenhauser C, Wiech T, Wild P, Welte T, von Stillfried S, Boor P. Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? Virchows Arch 2022. [PMID: 35364700 DOI: 10.1007/s00428-022-03319-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Couper K, Murrells T, Sanders J, Anderson JE, Blake H, Kelly D, Kent B, Maben J, Rafferty AM, Taylor RM, Harris R. The impact of COVID-19 on the wellbeing of the UK nursing and midwifery workforce during the first pandemic wave: a longitudinal survey study. International Journal of Nursing Studies 2021. [DOI: 10.1016/j.ijnurstu.2021.104155] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
380 Stefanou M, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, Giannopoulos S, Tsiodras S, Gaga M, Tsivgoulis G. Neurological manifestations of long-COVID syndrome: a narrative review. Therapeutic Advances in Chronic Disease 2022;13:204062232210768. [DOI: 10.1177/20406223221076890] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
381 Hong JSW, Atkinson LZ, Al-Juffali N, Awad A, Geddes JR, Tunbridge EM, Harrison PJ, Cipriani A. Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale. Mol Psychiatry 2021. [PMID: 34819636 DOI: 10.1038/s41380-021-01386-6] [Reference Citation Analysis]
382 Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, Stamatelopoulos K, Terpos E, Kotanidou A, Hagberg CA, Dimopoulos MA, Kontoyiannis DP. Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review. J Infect 2021;83:1-16. [PMID: 33992686 DOI: 10.1016/j.jinf.2021.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
383 Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, Tan BWQ, Avillach P, Brat GA, Hong C, Morris M, Visweswaran S, Patel LP, Gutiérrez-Sacristán A, Hanauer DA, Holmes JH, Samayamuthu MJ, Bourgeois FT, L'Yi S, Maidlow SE, Moal B, Murphy SN, Strasser ZH, Neuraz A, Ngiam KY, Loh NHW, Omenn GS, Prunotto A, Dalvin LA, Klann JG, Schubert P, Vidorreta FJS, Benoit V, Verdy G, Kavuluru R, Estiri H, Luo Y, Malovini A, Tibollo V, Bellazzi R, Cho K, Ho YL, Tan ALM, Tan BWL, Gehlenborg N, Lozano-Zahonero S, Jouhet V, Chiovato L, Aronow BJ, Toh EMS, Wong WGS, Pizzimenti S, Wagholikar KB, Bucalo M, Cai T, South AM, Kohane IS, Weber GM; Consortium for Clinical Characterization of COVID-19 by EHR (4CE). International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med 2022;5:81. [PMID: 35768548 DOI: 10.1038/s41746-022-00623-8] [Reference Citation Analysis]
384 Egede LE, Walker RJ, Dawson AZ, Zosel A, Bhandari S, Nagavally S, Martin I, Frank M. Short-term impact of COVID-19 on quality of life, perceived stress, and serious psychological distress in an adult population in the midwest United States. Qual Life Res 2022. [PMID: 35020111 DOI: 10.1007/s11136-022-03081-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
385 Warren CM, Snow TT, Lee AS, Shah MM, Heider A, Blomkalns A, Betts B, Buzzanco AS, Gonzalez J, Chinthrajah RS, Do E, Chang I, Dunham D, Lee G, O'Hara R, Park H, Shamji MH, Schilling L, Sindher SB, Sisodiya D, Smith E, Tsai M, Galli SJ, Akdis C, Nadeau KC. Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. JAMA Netw Open 2021;4:e2125524. [PMID: 34533570 DOI: 10.1001/jamanetworkopen.2021.25524] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]